{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T03:47:11Z","timestamp":1794023231693,"version":"4.8.0"},"reference-count":468,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005416","name":"Research Council of Norway","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022293","name":"Director Throne Holst's Fund for Nutrition Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022293","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008730","name":"The Norwegian Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008730","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["pharmrev.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reviews"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.pharmr.2026.100146","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T15:36:30Z","timestamp":1780500990000},"page":"100146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Aryl hydrocarbon receptor pharmacology\u2014mechanisms, ligands, and therapeutic potential"],"prefix":"10.1016","volume":"78","author":[{"given":"Raitis","family":"Bobrovs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ninni Elise","family":"Olafsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samaneh Shabani","family":"\u00c5hrling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9815-8636","authenticated-orcid":false,"given":"Jason","family":"Matthews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.pharmr.2026.100146_bib1","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0026-895X(25)13874-1","article-title":"Comparison of 2,3,7,8-tetrachlorodibenzo-p-dioxin, a potent inducer of aryl hydrocarbon hydroxylase, with 3-methylcholanthrene","volume":"10","author":"Poland","year":"1974","journal-title":"Mol Pharmacol"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100146_bib2","first-page":"2404","article-title":"2,3,7,8-Tetrachlorodibenzo-p-dioxin: environmental contaminant and molecular probe","volume":"35","author":"Poland","year":"1976","journal-title":"Fed Proc"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100146_bib3","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/nrc3846","article-title":"Aryl hydrocarbon receptor ligands in cancer: friend and foe","volume":"14","author":"Murray","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.pharmr.2026.100146_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115798","article-title":"The complex biology of aryl hydrocarbon receptor activation in cancer and beyond","volume":"216","author":"Opitz","year":"2023","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmr.2026.100146_bib5","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1146\/annurev.pa.35.040195.001515","article-title":"The aryl hydrocarbon receptor complex","volume":"35","author":"Hankinson","year":"1995","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100146_bib6","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/jbiol170","article-title":"Beyond toxicity: aryl hydrocarbon receptor-mediated functions in the immune system","volume":"8","author":"Stockinger","year":"2009","journal-title":"J Biol"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100146_bib7","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s41575-021-00430-8","article-title":"AHR in the intestinal microenvironment: safeguarding barrier function","volume":"18","author":"Stockinger","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100146_bib8","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S1357-2725(03)00211-5","article-title":"The mammalian basic helix-loop-helix\/PAS family of transcriptional regulators","volume":"36","author":"Kewley","year":"2004","journal-title":"Int J Biochem Cell Biol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100146_bib9","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1146\/annurev-physiol-021909-135922","article-title":"Mammalian Per-Arnt-Sim proteins in environmental adaptation","volume":"72","author":"McIntosh","year":"2010","journal-title":"Annu Rev Physiol"},{"issue":"33","key":"10.1016\/j.pharmr.2026.100146_bib10","doi-asserted-by":"crossref","first-page":"11148","DOI":"10.1021\/bi050948b","article-title":"The transactivation domain of the Ah receptor is a key determinant of cellular localization and ligand-independent nucleocytoplasmic shuttling properties","volume":"44","author":"Ramadoss","year":"2005","journal-title":"Biochemistry"},{"issue":"1-2","key":"10.1016\/j.pharmr.2026.100146_bib11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0009-2797(02)00064-9","article-title":"The role of chaperone proteins in the aryl hydrocarbon receptor core complex","volume":"141","author":"Petrulis","year":"2002","journal-title":"Chem Biol Interact"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100146_bib12","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nchembio.1185","article-title":"Allosteric inhibition of hypoxia inducible factor-2 with small molecules","volume":"9","author":"Scheuermann","year":"2013","journal-title":"Nat Chem Biol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100146_bib13","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1073\/pnas.0808092106","article-title":"Artificial ligand binding within the HIF2\u03b1 PAS-B domain of the HIF2 transcription factor","volume":"106","author":"Scheuermann","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100146_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107606","article-title":"Identification of small-molecule ligand-binding sites on and in the ARNT PAS-B domain","volume":"300","author":"Xu","year":"2024","journal-title":"J Biol Chem"},{"issue":"52","key":"10.1016\/j.pharmr.2026.100146_bib15","doi-asserted-by":"crossref","first-page":"21128","DOI":"10.1073\/pnas.1116123109","article-title":"Ligand-binding properties of a juvenile hormone receptor, Methoprene-tolerant","volume":"108","author":"Charles","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100146_bib16","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1111\/febs.16719","article-title":"Ligand-dependent protein interactions of the juvenile hormone receptor captured in real time","volume":"290","author":"Tumova","year":"2023","journal-title":"FEBS J"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100146_bib17","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.abb.2004.09.031","article-title":"Role of coactivators in transcriptional activation by the aryl hydrocarbon receptor","volume":"433","author":"Hankinson","year":"2005","journal-title":"Arch Biochem Biophys"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100146_bib18","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/s41577-019-0125-8","article-title":"The aryl hydrocarbon receptor: an environmental sensor integrating immune responses in health and disease","volume":"19","author":"Rothhammer","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.pharmr.2026.100146_bib19","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cotox.2017.01.012","article-title":"The aryl hydrocarbon receptor (AhR) as a drug target for cancer chemotherapy","volume":"2","author":"Safe","year":"2017","journal-title":"Curr Opin Toxicol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100146_bib20","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3390\/receptors2010005","article-title":"Aryl hydrocarbon receptor (AhR) signaling in colonic cells and tumors","volume":"2","author":"Safe","year":"2023","journal-title":"Receptors"},{"issue":"65","key":"10.1016\/j.pharmr.2026.100146_bib21","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/newbio236107a0","article-title":"Aryl hydrocarbon hydroxylase induction by polycyclic hydrocarbons: simple autosomal dominant trait in the mouse","volume":"236","author":"Nebert","year":"1972","journal-title":"Nat New Biol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100146_bib22","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/BF00486400","article-title":"The genetics of aryl hydrocarbon hydroxylase induction in mice: a single gene difference between C57BL-6J and DBA-2J","volume":"6","author":"Thomas","year":"1972","journal-title":"Biochem Genet"},{"issue":"23","key":"10.1016\/j.pharmr.2026.100146_bib23","doi-asserted-by":"crossref","first-page":"23847","DOI":"10.1074\/jbc.R400004200","article-title":"Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer","volume":"279","author":"Nebert","year":"2004","journal-title":"J Biol Chem"},{"issue":"18","key":"10.1016\/j.pharmr.2026.100146_bib24","doi-asserted-by":"crossref","first-page":"5851","DOI":"10.1016\/S0021-9258(20)79896-0","article-title":"Genetic expression of aryl hydrocarbon hydroxylase induction. Evidence for the involvement of other genetic loci","volume":"249","author":"Robinson","year":"1974","journal-title":"J Biol Chem"},{"issue":"17","key":"10.1016\/j.pharmr.2026.100146_bib25","doi-asserted-by":"crossref","first-page":"5599","DOI":"10.1016\/S0021-9258(20)79769-3","article-title":"Genetic expression of aryl hydrocarbon hydroxylase activity. Induction of monooxygenase activities and cytochrome P1-450 formation by 2,3,7,8-tetrachlorodibenzo-p-dioxin in mice genetically \u201cnonresponsive\u201d to other aromatic hydrocarbons","volume":"249","author":"Poland","year":"1974","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100146_bib26","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0026-895X(25)13282-3","article-title":"Cloning and expression of a human Ah receptor cDNA","volume":"44","author":"Dolwick","year":"1993","journal-title":"Mol Pharmacol"},{"issue":"29","key":"10.1016\/j.pharmr.2026.100146_bib27","doi-asserted-by":"crossref","first-page":"22203","DOI":"10.1016\/S0021-9258(20)80668-1","article-title":"Molecular characterization of the murine Ahr gene. Organization, promoter analysis, and chromosomal assignment","volume":"268","author":"Schmidt","year":"1993","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100146_bib28","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/00008571-199412000-00008","article-title":"A complete structure of the mouse Ah receptor gene","volume":"4","author":"Mimura","year":"1994","journal-title":"Pharmacogenetics"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100146_bib29","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S0026-895X(25)09468-4","article-title":"Characterization and strain distribution pattern of the murine Ah receptor specified by the Ahd and Ahb-3 alleles","volume":"38","author":"Poland","year":"1990","journal-title":"Mol Pharmacol"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100146_bib30","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0026-895X(25)09833-5","article-title":"Analysis of the four alleles of the murine aryl hydrocarbon receptor","volume":"46","author":"Poland","year":"1994","journal-title":"Mol Pharmacol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100146_bib31","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/toxsci\/kfab032","article-title":"Genetics-based approach to identify novel genes regulated by the aryl hydrocarbon receptor in mouse liver","volume":"181","author":"Jurgelewicz","year":"2021","journal-title":"Toxicol Sci"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100146_bib32","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1080\/03602532.2021.1955916","article-title":"Rodent genetic models of Ah receptor signaling","volume":"53","author":"Wilson","year":"2021","journal-title":"Drug Metab Rev"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100146_bib33","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3109\/10408448909017908","article-title":"The Ah locus: genetic differences in toxicity, cancer, mutation, and birth defects","volume":"20","author":"Nebert","year":"1989","journal-title":"Crit Rev Toxicol"},{"issue":"20","key":"10.1016\/j.pharmr.2026.100146_bib34","doi-asserted-by":"crossref","first-page":"17767","DOI":"10.1074\/jbc.M209594200","article-title":"Resistance to 2,3,7,8-tetrachlorodibenzo-p-dioxin toxicity and abnormal liver development in mice carrying a mutation in the nuclear localization sequence of the aryl hydrocarbon receptor","volume":"278","author":"Bunger","year":"2003","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100146_bib35","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/toxsci\/kfab005","article-title":"Generation of an allelic series at the Ahr locus using an edited recombinant approach","volume":"180","author":"Wilson","year":"2021","journal-title":"Toxicol Sci"},{"issue":"44","key":"10.1016\/j.pharmr.2026.100146_bib36","doi-asserted-by":"crossref","first-page":"27337","DOI":"10.1016\/S0021-9258(18)46990-6","article-title":"Dioxin binding activities of polymorphic forms of mouse and human arylhydrocarbon receptors","volume":"269","author":"Ema","year":"1994","journal-title":"J Biol Chem"},{"issue":"5211","key":"10.1016\/j.pharmr.2026.100146_bib37","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1126\/science.7732381","article-title":"Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor","volume":"268","author":"Fernandez-Salguero","year":"1995","journal-title":"Science"},{"issue":"13","key":"10.1016\/j.pharmr.2026.100146_bib38","doi-asserted-by":"crossref","first-page":"6731","DOI":"10.1073\/pnas.93.13.6731","article-title":"Characterization of a murine Ahr null allele: involvement of the Ah receptor in hepatic growth and development","volume":"93","author":"Schmidt","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100146_bib39","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1046\/j.1365-2443.1997.1490345.x","article-title":"Loss of teratogenic response to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice lacking the Ah (dioxin) receptor","volume":"2","author":"Mimura","year":"1997","journal-title":"Genes Cells"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100146_bib40","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0006-2952(98)00134-8","article-title":"Ahr null alleles: distinctive or different?","volume":"56","author":"Lahvis","year":"1998","journal-title":"Biochem Pharmacol"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100146_bib41","first-page":"1194","article-title":"The aryl hydrocarbon receptor: studies using the AHR-null mice","volume":"26","author":"Gonzalez","year":"1998","journal-title":"Drug Metab Dispos"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100146_bib42","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1021\/acs.chemrestox.9b00476","article-title":"The Ah receptor: adaptive metabolism, ligand diversity, and the xenokine model","volume":"33","author":"Avilla","year":"2020","journal-title":"Chem Res Toxicol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100146_bib43","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.taap.2013.06.024","article-title":"Knockout of the aryl hydrocarbon receptor results in distinct hepatic and renal phenotypes in rats and mice","volume":"272","author":"Harrill","year":"2013","journal-title":"Toxicol Appl Pharmacol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100146_bib44","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/jat.3211","article-title":"Aryl hydrocarbon receptor knockout rats are insensitive to the pathological effects of repeated oral exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin","volume":"36","author":"Harrill","year":"2016","journal-title":"J Appl Toxicol"},{"key":"10.1016\/j.pharmr.2026.100146_bib45","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1146\/annurev.pharmtox.43.100901.135828","article-title":"Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals","volume":"43","author":"Denison","year":"2003","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.pharmr.2026.100146_bib46","series-title":"Toxic equivalents procedure for dioxin and dioxin-like compounds","year":"2025"},{"key":"10.1016\/j.pharmr.2026.100146_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2023.105525","article-title":"The 2022 World Health Organization reevaluation of human and mammalian toxic equivalency factors for polychlorinated dioxins, dibenzofurans and biphenyls","volume":"146","author":"DeVito","year":"2024","journal-title":"Regul Toxicol Pharmacol"},{"key":"10.1016\/j.pharmr.2026.100146_bib48","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.chemosphere.2016.02.034","article-title":"Polychlorinated dibenzo-p-dioxins and dibenzofurans (PCDD\/Fs) and biphenyls (PCBs) in home-produced eggs","volume":"150","author":"Hoogenboom","year":"2016","journal-title":"Chemosphere"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100146_bib49","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.3390\/molecules29081788","article-title":"A comprehensive evaluation of dioxins and furans occurrence in river sediments from a secondary steel recycling craft village in northern Vietnam","volume":"29","author":"Nguyen","year":"2024","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100146_bib50","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1289\/ehp.11779","article-title":"The University of Michigan dioxin exposure study: predictors of human serum dioxin concentrations in Midland and Saginaw, Michigan","volume":"117","author":"Garabrant","year":"2009","journal-title":"Environ Health Perspect"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100146_bib51","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1124\/dmd.115.064246","article-title":"Indole and tryptophan metabolism: endogenous and dietary routes to Ah receptor activation","volume":"43","author":"Hubbard","year":"2015","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharmr.2026.100146_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115626","article-title":"Ligands and agonists of the aryl hydrocarbon receptor AhR: facts and myths","volume":"213","author":"Sladekova","year":"2023","journal-title":"Biochem Pharmacol"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100146_bib53","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1111\/bph.14988","article-title":"100 years of modelling ligand-receptor binding and response: a focus on GPCRs","volume":"177","author":"Finlay","year":"2020","journal-title":"Br J Pharmacol"},{"issue":"16","key":"10.1016\/j.pharmr.2026.100146_bib54","doi-asserted-by":"crossref","first-page":"4936","DOI":"10.1016\/S0021-9258(17)33205-2","article-title":"Stereospecific, high affinity binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin by hepatic cytosol. Evidence that the binding species is receptor for induction of aryl hydrocarbon hydroxylase","volume":"251","author":"Poland","year":"1976","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100146_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0003-2697(82)90212-3","article-title":"The examination and quantitation of tissue cytosolic receptors for 2,3,7,8-tetrachlorodibenzo-p-dioxin using hydroxylapatite","volume":"124","author":"Gasiewicz","year":"1982","journal-title":"Anal Biochem"},{"issue":"22","key":"10.1016\/j.pharmr.2026.100146_bib56","doi-asserted-by":"crossref","first-page":"11636","DOI":"10.1016\/S0021-9258(19)86532-8","article-title":"Regulatory gene product of the Ah locus. Characterization of the cytosolic inducer-receptor complex and evidence for its nuclear translocation","volume":"254","author":"Okey","year":"1979","journal-title":"J Biol Chem"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100146_bib57","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1139\/y81-143","article-title":"Rapid vertical tube rotor gradient assay for binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin to the Ah receptor","volume":"59","author":"Tsui","year":"1981","journal-title":"Can J Physiol Pharmacol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100146_bib58","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/toxsci\/kfm085","article-title":"Persistent binding of ligands to the aryl hydrocarbon receptor","volume":"98","author":"Bohonowych","year":"2007","journal-title":"Toxicol Sci"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100146_bib59","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1093\/toxsci\/kfn011","article-title":"Newspapers and newspaper ink contain agonists for the Ah receptor","volume":"102","author":"Bohonowych","year":"2008","journal-title":"Toxicol Sci"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100146_bib60","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.talanta.2004.05.032","article-title":"Recombinant cell bioassay systems for the detection and relative quantitation of halogenated dioxins and related chemicals","volume":"63","author":"Denison","year":"2004","journal-title":"Talanta"},{"key":"10.1016\/j.pharmr.2026.100146_bib61","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.chemosphere.2018.12.115","article-title":"Bioassay system for the detection of aryl hydrocarbon receptor agonists in waterborne pesticides using zebrafish cyp1a1 promoter-luciferase recombinant hepatic cells","volume":"220","author":"Zhou","year":"2019","journal-title":"Chemosphere"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100146_bib62","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1038\/s41467-020-16901-6","article-title":"Author correction: HIF1\u03b1 inhibition facilitates leflunomide-AHR-CRP signaling to attenuate bone erosion in CRP-aberrant rheumatoid arthritis","volume":"11","author":"Liang","year":"2020","journal-title":"Nat Commun"},{"issue":"62","key":"10.1016\/j.pharmr.2026.100146_bib63","doi-asserted-by":"crossref","first-page":"105995","DOI":"10.18632\/oncotarget.22519","article-title":"1,8-Cineole prevents UVB-induced skin carcinogenesis by targeting the aryl hydrocarbon receptor","volume":"8","author":"Lee","year":"2017","journal-title":"Oncotarget"},{"issue":"24","key":"10.1016\/j.pharmr.2026.100146_bib64","doi-asserted-by":"crossref","first-page":"16268","DOI":"10.1021\/acs.jmedchem.2c00956","article-title":"The highly potent AhR agonist Picoberin modulates Hh-dependent osteoblast differentiation","volume":"65","author":"Flegel","year":"2022","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmr.2026.100146_bib65","doi-asserted-by":"crossref","DOI":"10.1038\/srep32009","article-title":"The Q-rich\/PST domain of the AHR regulates both ligand-induced nuclear transport and nucleocytoplasmic shuttling","volume":"6","author":"Tkachenko","year":"2016","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100146_bib66","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1038\/s41467-023-38478-6","article-title":"Monoterpenoid aryl hydrocarbon receptor allosteric antagonists protect against ultraviolet skin damage in female mice","volume":"14","author":"Ondrova","year":"2023","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100146_bib67","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3390\/bios11030060","article-title":"Novel method for quantifying AhR-ligand binding affinities using microscale thermophoresis","volume":"11","author":"Stinn","year":"2021","journal-title":"Biosensors"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100146_bib68","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1038\/s41467-025-56574-7","article-title":"Structural basis for the ligand-dependent activation of heterodimeric AHR-ARNT complex","volume":"16","author":"Diao","year":"2025","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100146_bib69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/toxsci\/kfr218","article-title":"Exactly the same but different: promiscuity and diversity in the molecular mechanisms of action of the aryl hydrocarbon (dioxin) receptor","volume":"124","author":"Denison","year":"2011","journal-title":"Toxicol Sci"},{"issue":"18","key":"10.1016\/j.pharmr.2026.100146_bib70","doi-asserted-by":"crossref","first-page":"6654","DOI":"10.3390\/ijms21186654","article-title":"Aryl hydrocarbon receptor (AHR) ligands as selective AHR modulators (SAhRMs)","volume":"21","author":"Safe","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.pharmr.2026.100146_bib71","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.cotox.2017.01.006","article-title":"And now for something completely different: diversity in ligand-dependent activation of Ah receptor responses","volume":"2","author":"Denison","year":"2017","journal-title":"Curr Opin Toxicol"},{"issue":"19","key":"10.1016\/j.pharmr.2026.100146_bib72","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241914578","article-title":"Resveratrol and 3,3'-diindolylmethane differentially regulate aryl hydrocarbon receptor and estrogen receptor alpha activity through multiple transcriptomic targets in MCF-7 human breast cancer cells","volume":"24","author":"Das","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100146_bib73","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1006\/taap.2000.9026","article-title":"Relative contributions of affinity and intrinsic efficacy to aryl hydrocarbon receptor ligand potency","volume":"168","author":"Hestermann","year":"2000","journal-title":"Toxicol Appl Pharmacol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100146_bib74","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0003-9861(87)90485-1","article-title":"Synthesis and aryl hydrocarbon receptor binding properties of radiolabeled polychlorinated dibenzofuran congeners","volume":"259","author":"Farrell","year":"1987","journal-title":"Arch Biochem Biophys"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100146_bib75","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202503414","article-title":"Beneficial and detrimental consequences of AHR activation in intestinal infection","volume":"8","author":"Diaz","year":"2025","journal-title":"Life Sci Alliance"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100146_bib76","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1007\/s40265-022-01748-6","article-title":"Tapinarof cream 1%: first approval","volume":"82","author":"Keam","year":"2022","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100146_bib77","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s40272-025-00689-3","article-title":"Tapinarof cream 1%: pediatric first approval","volume":"27","author":"Hoy","year":"2025","journal-title":"Paediatr Drugs"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100146_bib78","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1016\/j.jid.2017.05.004","article-title":"Tapinarof is a natural AhR agonist that resolves skin inflammation in mice and humans","volume":"137","author":"Smith","year":"2017","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100146_bib79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaci.2023.12.013","article-title":"Tapinarof validates the aryl hydrocarbon receptor as a therapeutic target: a clinical review","volume":"154","author":"Silverberg","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.pharmr.2026.100146_bib80","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ejmech.2012.10.055","article-title":"Synthesis of novel therapeutic agents for the treatment of multiple sclerosis: a brief overview","volume":"60","author":"Mulakayala","year":"2013","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.pharmr.2026.100146_bib81","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jneuroim.2016.06.003","article-title":"The immunomodulatory effect of laquinimod in CNS autoimmunity is mediated by the aryl hydrocarbon receptor","volume":"298","author":"Berg","year":"2016","journal-title":"J Neuroimmunol"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100146_bib82","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1136\/gutjnl-2014-307118","article-title":"A phase II study of laquinimod in Crohn's disease","volume":"64","author":"D'Haens","year":"2015","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100146_bib83","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0088726","article-title":"Benzimidazoisoquinolines: a new class of rapidly metabolized aryl hydrocarbon receptor (AhR) ligands that induce AhR-dependent Tregs and prevent murine graft-versus-host disease","volume":"9","author":"Punj","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmr.2026.100146_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2025.117066","article-title":"Novel aryl hydrocarbon receptor agonists as potential anti-inflammatory therapeutics: identification and validation through drug repurposing","volume":"240","author":"Haupt","year":"2025","journal-title":"Biochem Pharmacol"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100146_bib85","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.22232","article-title":"Identification of aryl hydrocarbon receptor allosteric antagonists from clinically approved drugs","volume":"85","author":"Mosa","year":"2024","journal-title":"Drug Dev Res"},{"issue":"20","key":"10.1016\/j.pharmr.2026.100146_bib86","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1042\/BCJ20170583","article-title":"Carbidopa is an activator of aryl hydrocarbon receptor with potential for cancer therapy","volume":"474","author":"Ogura","year":"2017","journal-title":"Biochem J"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100146_bib87","first-page":"141","article-title":"Tranilast Kissei pharmaceutical","volume":"1","author":"Konneh","year":"1998","journal-title":"IDrugs"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100146_bib88","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1039\/D1MD00015B","article-title":"Recent advances in the development of AHR antagonists in immuno-oncology","volume":"12","author":"Sun","year":"2021","journal-title":"RSC Med Chem"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100146_bib89","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0026-895X(25)13161-1","article-title":"6-Methyl-1,3,8-trichlorodibenzofuran as a 2,3,7,8-tetrachlorodibenzo-p-dioxin antagonist: inhibition of the induction of rat cytochrome P-450 isozymes and related monooxygenase activities","volume":"33","author":"Astroff","year":"1988","journal-title":"Mol Pharmacol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100146_bib90","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/0003-9861(90)90416-V","article-title":"The mechanism of action of \u03b1-naphthoflavone as an inhibitor of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced CYP1A1 gene expression","volume":"281","author":"Merchant","year":"1990","journal-title":"Arch Biochem Biophys"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100146_bib91","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0003-9861(92)90426-W","article-title":"Mechanism of action of aryl hydrocarbon receptor antagonists: inhibition of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced CYP1A1 gene expression","volume":"298","author":"Merchant","year":"1992","journal-title":"Arch Biochem Biophys"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100146_bib92","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0026-895X(25)13600-6","article-title":"Alpha-naphthoflavone-induced CYP1A1 gene expression and cytosolic aryl hydrocarbon receptor transformation","volume":"43","author":"Santostefano","year":"1993","journal-title":"Mol Pharmacol"},{"issue":"17","key":"10.1016\/j.pharmr.2026.100146_bib93","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1016\/0006-2952(86)90481-8","article-title":"Inhibition of aromatase cytochrome P-450 (estrogen synthetase) by derivatives of \u03b1-naphthoflavone","volume":"35","author":"Kellis","year":"1986","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100146_bib94","first-page":"1123","article-title":"Mechanism of action and development of selective aryl hydrocarbon receptor modulators for treatment of hormone-dependent cancers (review)","volume":"20","author":"Safe","year":"2002","journal-title":"Int J Oncol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100146_bib95","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1124\/mol.105.021832","article-title":"Novel compound 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazo-phenyl)-amide (CH-223191) prevents 2,3,7,8-TCDD-induced toxicity by antagonizing the aryl hydrocarbon receptor","volume":"69","author":"Kim","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmr.2026.100146_bib96","series-title":"Compound having activity for inhibiting dioxin toxicity, pharmaceutical composition comprising the compound and method for treating disease resulting from dioxin toxicity using the compound. US patent application US20070032458","author":"Suh","year":"2006"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100146_bib97","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/toxsci\/kfq217","article-title":"CH223191 is a ligand-selective antagonist of the Ah (dioxin) receptor","volume":"117","author":"Zhao","year":"2010","journal-title":"Toxicol Sci"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100146_bib98","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1021\/jm0498194","article-title":"Synthesis and biological properties of new stilbene derivatives of resveratrol as new selective aryl hydrocarbon modulators","volume":"48","author":"de Medina","year":"2005","journal-title":"J Med Chem"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100146_bib99","doi-asserted-by":"crossref","first-page":"4682","DOI":"10.1172\/JCI70712","article-title":"Inhibition of the aryl hydrocarbon receptor\/polyamine biosynthesis axis suppresses multiple myeloma","volume":"128","author":"Bianchi-Smiraglia","year":"2018","journal-title":"J Clin Invest"},{"issue":"5997","key":"10.1016\/j.pharmr.2026.100146_bib100","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1126\/science.1191536","article-title":"Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells","volume":"329","author":"Boitano","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.pharmr.2026.100146_bib101","article-title":"IRM LLC, Scripps Research Institute, assignees. Compounds that expand hematopoietic stem cells","author":"Boitano","year":"2009","journal-title":"Patent"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100146_bib102","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1124\/jpet.110.178392","article-title":"Identification of a high-affinity ligand that exhibits complete aryl hydrocarbon receptor antagonism","volume":"338","author":"Smith","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100146_bib103","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1124\/mol.114.093369","article-title":"In silico identification of an aryl hydrocarbon receptor antagonist with biological activity in vitro and in vivo","volume":"86","author":"Parks","year":"2014","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmr.2026.100146_bib104","series-title":"inventors; Northeastern University China, Boston University, Northeastern University Boston, Boston Medical Center Corp, assignees. Aryl hydrocarbon receptor (AHR) modifiers as novel cancer therapeutics","author":"Sherr","year":"2011"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100146_bib105","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1038\/jid.2015.6","article-title":"Genetic and pharmacological analysis identifies a physiological role for the AHR in epidermal differentiation","volume":"135","author":"van den Bogaard","year":"2015","journal-title":"J Invest Dermatol"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100146_bib106","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1111\/bph.12576","article-title":"In vivo effects of the pure aryl hydrocarbon receptor antagonist GNF-351 after oral administration are limited to the gastrointestinal tract","volume":"171","author":"Fang","year":"2014","journal-title":"Br J Pharmacol"},{"issue":"13 Suppl","key":"10.1016\/j.pharmr.2026.100146_bib107","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1158\/1538-7445.AM2019-1210","article-title":"Abstract 1210: targeting the IDO1-kynurenine-AhR pathway for cancer immunotherapy","volume":"79","author":"Pinto","year":"2019","journal-title":"Cancer Res"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100146_bib108","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1039\/D4MD00266K","article-title":"Discovery and optimisation of pyrazolo[1,5-a]pyrimidines as aryl hydrocarbon receptor antagonists","volume":"15","author":"Bobrovs","year":"2024","journal-title":"RSC Med Chem"},{"key":"10.1016\/j.pharmr.2026.100146_bib109","series-title":"Indole AHR inhibitors and uses thereof","author":"Castro","year":"2018"},{"key":"10.1016\/j.pharmr.2026.100146_bib110","article-title":"assignees. 2-Heteroaryl-3-oxo-2,3-dihydropyridazine-4-carboxamides for the treatment of cancer","author":"Gutcher","year":"2018","journal-title":"Patent"},{"key":"10.1016\/j.pharmr.2026.100146_bib113","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2021.734334","article-title":"Indoles derived from glucobrassicin: cancer chemoprevention by indole-3-carbinol and 3,3'-diindolylmethane","volume":"8","author":"Williams","year":"2021","journal-title":"Front Nutr"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100146_bib114","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/0006-2952(93)90258-X","article-title":"Ah receptor binding properties of indole carbinols and induction of hepatic estradiol hydroxylation","volume":"45","author":"Jellinck","year":"1993","journal-title":"Biochem Pharmacol"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100146_bib115","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/0006-2952(96)00060-3","article-title":"Indole-3-carbinol and diindolylmethane as aryl hydrocarbon (Ah) receptor agonists and antagonists in T47D human breast cancer cells","volume":"51","author":"Chen","year":"1996","journal-title":"Biochem Pharmacol"},{"issue":"21","key":"10.1016\/j.pharmr.2026.100146_bib116","doi-asserted-by":"crossref","first-page":"9543","DOI":"10.1073\/pnas.88.21.9543","article-title":"Aromatic hydrocarbon responsiveness-receptor agonists generated from indole-3-carbinol in vitro and in vivo: comparisons with 2,3,7,8-tetrachlorodibenzo-p-dioxin","volume":"88","author":"Bjeldanes","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100146_bib117","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0006-2952(00)00307-5","article-title":"Ligand-independent activation of estrogen receptor function by 3,3'-diindolylmethane in human breast cancer cells","volume":"60","author":"Riby","year":"2000","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100146_bib118","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1038\/s41467-024-46559-3","article-title":"Diindoles produced from commensal microbiota metabolites function as endogenous CAR\/Nr1i3 ligands","volume":"15","author":"Liu","year":"2024","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100146_bib119","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.toxlet.2014.12.015","article-title":"Diindolylmethane, a naturally occurring compound, induces CYP3A4 and MDR1 gene expression by activating human PXR","volume":"232","author":"Pondugula","year":"2015","journal-title":"Toxicol Lett"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100146_bib120","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3390\/medicines5030093","article-title":"Flavonoids and other phenolic compounds from medicinal plants for pharmaceutical and medical aspects: an overview","volume":"5","author":"Tungmunnithum","year":"2018","journal-title":"Medicines"},{"issue":"23","key":"10.1016\/j.pharmr.2026.100146_bib121","doi-asserted-by":"crossref","first-page":"5760","DOI":"10.3390\/molecules29235760","article-title":"Flavonoids and other polyphenols: bioactive molecules from traditional medicine recipes\/medicinal plants and their potential for phytopharmaceutical and medical application","volume":"29","author":"Intharuksa","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.pharmr.2026.100146_bib122","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102622","article-title":"Targeting the aryl hydrocarbon receptor by gut phenolic metabolites: a strategy towards gut inflammation","volume":"61","author":"Pinto","year":"2023","journal-title":"Redox Biol"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100146_bib123","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.3390\/molecules26082315","article-title":"Plant occurring flavonoids as modulators of the aryl hydrocarbon receptor","volume":"26","author":"Goya-Jorge","year":"2021","journal-title":"Molecules"},{"issue":"Pt 3","key":"10.1016\/j.pharmr.2026.100146_bib124","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1042\/bj3400715","article-title":"Dietary flavonols quercetin and kaempferol are ligands of the aryl hydrocarbon receptor that affect CYP1A1 transcription differentially","volume":"340","author":"Ciolino","year":"1999","journal-title":"Biochem J"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100146_bib125","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/toxsci\/kfy075","article-title":"Structure-dependent modulation of aryl hydrocarbon receptor-mediated activities by flavonoids","volume":"164","author":"Jin","year":"2018","journal-title":"Toxicol Sci"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100146_bib126","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/S0026-895X(24)12541-2","article-title":"Resveratrol has antagonist activity on the aryl hydrocarbon receptor: implications for prevention of dioxin toxicity","volume":"56","author":"Casper","year":"1999","journal-title":"Mol Pharmacol"},{"issue":"24","key":"10.1016\/j.pharmr.2026.100146_bib127","first-page":"5707","article-title":"Resveratrol inhibits transcription of CYP1A1 in vitro by preventing activation of the aryl hydrocarbon receptor","volume":"58","author":"Ciolino","year":"1998","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100146_bib128","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.canlet.2010.08.010","article-title":"Inhibition of aryl hydrocarbon receptor-dependent transcription by resveratrol or kaempferol is independent of estrogen receptor \u03b1 expression in human breast cancer cells","volume":"299","author":"Macpherson","year":"2010","journal-title":"Cancer Lett"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100146_bib129","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/toxsci\/kfp079","article-title":"Resveratrol inhibits dioxin-induced expression of human CYP1A1 and CYP1B1 by inhibiting recruitment of the aryl hydrocarbon receptor complex and RNA polymerase II to the regulatory regions of the corresponding genes","volume":"110","author":"Beedanagari","year":"2009","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.pharmr.2026.100146_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114845","article-title":"An overview of aryl hydrocarbon receptor ligands in the last two decades (2002\u20132022): a medicinal chemistry perspective","volume":"244","author":"Lin","year":"2022","journal-title":"Eur J Med Chem"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100146_bib131","doi-asserted-by":"crossref","first-page":"4479","DOI":"10.1073\/pnas.1118467109","article-title":"Inhibition of cytochrome P4501-dependent clearance of the endogenous agonist FICZ as a mechanism for activation of the aryl hydrocarbon receptor","volume":"109","author":"Wincent","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"33","key":"10.1016\/j.pharmr.2026.100146_bib132","doi-asserted-by":"crossref","first-page":"11508","DOI":"10.1021\/bi980087p","article-title":"Activation of the Ah receptor by tryptophan and tryptophan metabolites","volume":"37","author":"Heath-Pagliuso","year":"1998","journal-title":"Biochemistry"},{"issue":"32","key":"10.1016\/j.pharmr.2026.100146_bib133","doi-asserted-by":"crossref","first-page":"15422","DOI":"10.1016\/S0021-9258(18)47743-5","article-title":"Certain photooxidized derivatives of tryptophan bind with very high affinity to the Ah receptor and are likely to be endogenous signal substances","volume":"262","author":"Rannug","year":"1987","journal-title":"J Biol Chem"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100146_bib134","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1080\/10408444.2018.1493086","article-title":"The tryptophan derivative 6-formylindolo[3,2-b]carbazole, FICZ, a dynamic mediator of endogenous aryl hydrocarbon receptor signaling, balances cell growth and differentiation","volume":"48","author":"Rannug","year":"2018","journal-title":"Crit Rev Toxicol"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100146_bib135","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1515\/BC.2006.143","article-title":"The aryl hydrocarbon receptor and light","volume":"387","author":"Rannug","year":"2006","journal-title":"Biol Chem"},{"issue":"6349","key":"10.1016\/j.pharmr.2026.100146_bib136","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaf9794","article-title":"Kynurenines: tryptophan's metabolites in exercise, inflammation, and mental health","volume":"357","author":"Cervenka","year":"2017","journal-title":"Science"},{"issue":"7368","key":"10.1016\/j.pharmr.2026.100146_bib137","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nature10491","article-title":"An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor","volume":"478","author":"Opitz","year":"2011","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100146_bib138","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1074\/jbc.RA117.000631","article-title":"Trace derivatives of kynurenine potently activate the aryl hydrocarbon receptor (AHR)","volume":"293","author":"Seok","year":"2018","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100146_bib139","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.cell.2020.07.038","article-title":"IL4I1 is a metabolic immune checkpoint that activates the AHR and promotes tumor progression","volume":"182","author":"Sadik","year":"2020","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100146_bib140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087877","article-title":"Identification of cinnabarinic acid as a novel endogenous aryl hydrocarbon receptor ligand that drives IL-22 production","volume":"9","author":"Lowe","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100146_bib141","doi-asserted-by":"crossref","first-page":"G433","DOI":"10.1152\/ajpgi.00337.2024","article-title":"Cinnabarinic acid protects against metabolic dysfunction-associated steatohepatitis by activating aryl hydrocarbon receptor-dependent AMPK signaling","volume":"328","author":"Patil","year":"2025","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100146_bib142","doi-asserted-by":"crossref","first-page":"6103","DOI":"10.1038\/s41598-018-24213-5","article-title":"Serotonin is an endogenous regulator of intestinal CYP1A1 via AhR","volume":"8","author":"Manzella","year":"2018","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100146_bib143","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1038\/s41467-018-05470-4","article-title":"Microbial tryptophan catabolites in health and disease","volume":"9","author":"Roager","year":"2018","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100146_bib144","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19490976.2020.1788899","article-title":"Intestinal microbiota-derived tryptophan metabolites are predictive of Ah receptor activity","volume":"12","author":"Dong","year":"2020","journal-title":"Gut Microbes"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100146_bib145","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.chom.2018.05.003","article-title":"Gut microbiota regulation of tryptophan metabolism in health and disease","volume":"23","author":"Agus","year":"2018","journal-title":"Cell Host Microbe"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100146_bib146","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.3390\/ijms21072614","article-title":"Gut microbial catabolites of tryptophan are ligands and agonists of the aryl hydrocarbon receptor: a detailed characterization","volume":"21","author":"Vyhlidalova","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.pharmr.2026.100146_bib147","doi-asserted-by":"crossref","DOI":"10.1038\/srep12689","article-title":"Adaptation of the human aryl hydrocarbon receptor to sense microbiota-derived indoles","volume":"5","author":"Hubbard","year":"2015","journal-title":"Sci Rep"},{"issue":"62","key":"10.1016\/j.pharmr.2026.100146_bib148","doi-asserted-by":"crossref","first-page":"105615","DOI":"10.18632\/oncotarget.22350","article-title":"Indirubin, a bisindole alkaloid from Isatis indigotica, reduces H1N1 susceptibility in stressed mice by regulating MAVS signaling","volume":"8","author":"Jie","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100146_bib149","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3390\/metabo8040086","article-title":"Urolithin A is a dietary microbiota-derived human aryl hydrocarbon receptor antagonist","volume":"8","author":"Muku","year":"2018","journal-title":"Metabolites"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100146_bib150","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.abb.2006.02.008","article-title":"A potential endogenous ligand for the aryl hydrocarbon receptor has potent agonist activity in vitro and in vivo","volume":"450","author":"Henry","year":"2006","journal-title":"Arch Biochem Biophys"},{"issue":"23","key":"10.1016\/j.pharmr.2026.100146_bib151","doi-asserted-by":"crossref","first-page":"14694","DOI":"10.1073\/pnas.232562899","article-title":"A ligand for the aryl hydrocarbon receptor isolated from lung","volume":"99","author":"Song","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"23","key":"10.1016\/j.pharmr.2026.100146_bib152","doi-asserted-by":"crossref","first-page":"7594","DOI":"10.1021\/bi982861e","article-title":"Lipoxin A4: a new class of ligand for the Ah receptor","volume":"38","author":"Schaldach","year":"1999","journal-title":"Biochemistry"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100146_bib153","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/jbt.16","article-title":"Activation of the Ah receptor signaling pathway by prostaglandins","volume":"15","author":"Seidel","year":"2001","journal-title":"J Biochem Mol Toxicol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100146_bib154","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1124\/mol.52.4.590","article-title":"Aryl hydrocarbon receptor-dependent induction of CYP1A1 by bilirubin in mouse hepatoma Hepa 1c1c7 cells","volume":"52","author":"Sinal","year":"1997","journal-title":"Mol Pharmacol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100146_bib155","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1006\/abbi.1998.0814","article-title":"Activation of the Ah receptor signal transduction pathway by bilirubin and biliverdin","volume":"357","author":"Phelan","year":"1998","journal-title":"Arch Biochem Biophys"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100146_bib156","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1615\/CritRevEukarGeneExpr.v18.i3.20","article-title":"The aryl hydrocarbon receptor complex and the control of gene expression","volume":"18","author":"Beischlag","year":"2008","journal-title":"Crit Rev Eukaryot Gene Expr"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100146_bib157","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/S0006-2952(96)00566-7","article-title":"Identification of c-Src as the integral component of the cytosolic Ah receptor complex, transducing the signal of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) through the protein phosphorylation pathway","volume":"52","author":"Enan","year":"1996","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100146_bib158","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1006\/bbrc.2001.5987","article-title":"TCDD-inducible poly(ADP-ribose) polymerase: a novel response to 2,3,7,8-tetrachlorodibenzo-p-dioxin","volume":"289","author":"Ma","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"issue":"1-2","key":"10.1016\/j.pharmr.2026.100146_bib159","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0009-2797(02)00065-0","article-title":"The mechanism of AH receptor protein down-regulation (degradation) and its impact on AH receptor-mediated gene regulation","volume":"141","author":"Pollenz","year":"2002","journal-title":"Chem Biol Interact"},{"issue":"7135","key":"10.1016\/j.pharmr.2026.100146_bib160","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/nature05683","article-title":"Dioxin receptor is a ligand-dependent E3 ubiquitin ligase","volume":"446","author":"Ohtake","year":"2007","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100146_bib161","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41392-020-0181-3","article-title":"The deubiquitylase UCHL3 maintains cancer stem-like properties by stabilizing the aryl hydrocarbon receptor","volume":"5","author":"Ouyang","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.pharmr.2026.100146_bib162","article-title":"Systematic identification and characterization of regulators of aryl hydrocarbon receptor signaling","author":"Verma","year":"2025","journal-title":"bioRxiv"},{"issue":"16","key":"10.1016\/j.pharmr.2026.100146_bib163","doi-asserted-by":"crossref","first-page":"16326","DOI":"10.1074\/jbc.M400784200","article-title":"Patent ductus venosus and dioxin resistance in mice harboring a hypomorphic Arnt allele","volume":"279","author":"Walisser","year":"2004","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100146_bib164","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1538\/expanim.16-0092","article-title":"The aryl hydrocarbon receptor: a multifunctional chemical sensor for host defense and homeostatic maintenance","volume":"66","author":"Kawajiri","year":"2017","journal-title":"Exp Anim"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100146_bib165","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.abb.2007.03.038","article-title":"Cytochrome P450 gene regulation and physiological functions mediated by the aryl hydrocarbon receptor","volume":"464","author":"Kawajiri","year":"2007","journal-title":"Arch Biochem Biophys"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100146_bib166","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/toxsci\/kfm096","article-title":"An aryl hydrocarbon receptor odyssey to the shores of toxicology: the Deichmann Lecture, International Congress of Toxicology-XI","volume":"98","author":"Okey","year":"2007","journal-title":"Toxicol Sci"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100146_bib167","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1124\/mol.106.032748","article-title":"Induction of CYP1A1 is a nonspecific biomarker of aryl hydrocarbon receptor activation: results of large-scale screening of pharmaceuticals and toxicants in vivo and in vitro","volume":"71","author":"Hu","year":"2007","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmr.2026.100146_bib168","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.cotox.2017.01.007","article-title":"Is chronic AhR activation by rapidly metabolized ligands safe for the treatment of immune-mediated diseases?","volume":"2","author":"Ehrlich","year":"2017","journal-title":"Curr Opin Toxicol"},{"issue":"7640","key":"10.1016\/j.pharmr.2026.100146_bib169","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/nature21080","article-title":"Feedback control of AHR signalling regulates intestinal immunity","volume":"542","author":"Schiering","year":"2017","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100146_bib170","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1101\/gad.13.1.20","article-title":"Identification of a novel mechanism of regulation of Ah (dioxin) receptor function","volume":"13","author":"Mimura","year":"1999","journal-title":"Genes Dev"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100146_bib171","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1124\/mol.107.040204","article-title":"Repression of aryl hydrocarbon receptor (AHR) signaling by AHR repressor: role of DNA binding and competition for AHR nuclear translocator","volume":"73","author":"Evans","year":"2008","journal-title":"Mol Pharmacol"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100146_bib172","doi-asserted-by":"crossref","first-page":"7939","DOI":"10.3390\/ijms15057939","article-title":"Aryl hydrocarbon receptor repressor and TiPARP (ARTD14) use similar, but also distinct mechanisms to repress aryl hydrocarbon receptor signaling","volume":"15","author":"MacPherson","year":"2014","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100146_bib173","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.bbrc.2007.11.016","article-title":"Inducibility of cytochrome P450 1A1 and chemical carcinogenesis by benzo[a]pyrene in AhR repressor-deficient mice","volume":"365","author":"Hosoya","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"issue":"23","key":"10.1016\/j.pharmr.2026.100146_bib174","doi-asserted-by":"crossref","first-page":"7399","DOI":"10.1111\/febs.16142","article-title":"ADP-ribosyltransferases, an update on function and nomenclature","volume":"289","author":"Luscher","year":"2021","journal-title":"FEBS J"},{"issue":"27","key":"10.1016\/j.pharmr.2026.100146_bib175","doi-asserted-by":"crossref","first-page":"16824","DOI":"10.1074\/jbc.M115.660100","article-title":"Loss of the mono-ADP-ribosyltransferase, TIPARP, increases sensitivity to dioxin-induced steatohepatitis and lethality","volume":"290","author":"Ahmed","year":"2015","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100146_bib176","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/toxsci\/kfab075","article-title":"2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)-inducible poly-ADP-ribose polymerase (TIPARP\/PARP7) catalytic mutant mice (TiparpH532A) have increased sensitivity to TCDD-induced hepatotoxicity and lethality","volume":"183","author":"Hutin","year":"2021","journal-title":"Toxicol Sci"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100146_bib177","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1093\/nar\/gks1337","article-title":"2,3,7,8-Tetrachlorodibenzo-p-dioxin poly(ADP-ribose) polymerase (TiPARP, ARTD14) is a mono-ADP-ribosyltransferase and repressor of aryl hydrocarbon receptor transactivation","volume":"41","author":"MacPherson","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.pharmr.2026.100146_bib178","article-title":"Discovery of ester-linked ubiquitylation of PARP10 mono-ADP-ribosylation in cells: a dual post-translational modification on Glu\/Asp side chains","author":"Bejan","year":"2024","journal-title":"bioRxiv"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100146_bib179","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1038\/s44318-025-00391-7","article-title":"Ubiquitin is directly linked via an ester to protein-conjugated mono-ADP-ribose","volume":"44","author":"Bejan","year":"2025","journal-title":"EMBO J"},{"key":"10.1016\/j.pharmr.2026.100146_bib180","doi-asserted-by":"crossref","DOI":"10.1038\/s44318-025-00656-1","article-title":"Ubiquitin pathway blockade reveals endogenous ADP-ribosylation marking PARP7 and AHR for degradation","author":"Gorelik","year":"2025","journal-title":"EMBO J"},{"issue":"21","key":"10.1016\/j.pharmr.2026.100146_bib181","doi-asserted-by":"crossref","first-page":"5993","DOI":"10.1038\/s44318-025-00577-z","article-title":"RNF114 and RNF166 exemplify reader-writer E3 ligases that extend K11 polyubiquitin onto sites of MARUbylation","volume":"44","author":"Lacoursiere","year":"2025","journal-title":"EMBO J"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100146_bib182","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100886","article-title":"Roles of the ubiquitin ligase CUL4B and ADP-ribosyltransferase TiPARP in TCDD-induced nuclear export and proteasomal degradation of the transcription factor AHR","volume":"297","author":"Rijo","year":"2021","journal-title":"J Biol Chem"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100146_bib183","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1002\/jcp.24092","article-title":"SUMOylation of AhR modulates its activity and stability through inhibiting its ubiquitination","volume":"227","author":"Xing","year":"2012","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.pharmr.2026.100146_bib184","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115371","article-title":"Functions of the aryl hydrocarbon receptor (AHR) beyond the canonical AHR\/ARNT signaling pathway","volume":"208","author":"Sondermann","year":"2023","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100146_bib185","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.bbrc.2004.04.090","article-title":"A novel induction mechanism of the rat CYP1A2 gene mediated by Ah receptor-Arnt heterodimer","volume":"318","author":"Sogawa","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100146_bib186","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.bbrc.2004.06.177","article-title":"Dioxin-responsive AHRE-II gene battery: identification by phylogenetic footprinting","volume":"321","author":"Boutros","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100146_bib187","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1124\/jpet.113.203786","article-title":"The tumor suppressor Kruppel-like factor 6 is a novel aryl hydrocarbon receptor DNA binding partner","volume":"345","author":"Wilson","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100146_bib188","doi-asserted-by":"crossref","first-page":"8119","DOI":"10.1038\/s41598-017-08680-w","article-title":"Kruppel-like factor 6 is a transcriptional activator of autophagy in acute liver injury","volume":"7","author":"Sydor","year":"2017","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100146_bib189","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1124\/mol.113.089730","article-title":"Ah receptor-mediated suppression of liver regeneration through NC-XRE-driven p21Cip1 expression","volume":"85","author":"Jackson","year":"2014","journal-title":"Mol Pharmacol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100146_bib190","doi-asserted-by":"crossref","DOI":"10.1093\/toxsci\/kfaf146","article-title":"Functional genomic analysis of non-canonical DNA regulatory elements of the aryl hydrocarbon receptor","volume":"209","author":"Shahriar","year":"2025","journal-title":"Toxicol Sci"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100146_bib191","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/ni.1912","article-title":"The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27","volume":"11","author":"Apetoh","year":"2010","journal-title":"Nat Immunol"},{"issue":"17","key":"10.1016\/j.pharmr.2026.100146_bib192","doi-asserted-by":"crossref","first-page":"12115","DOI":"10.1074\/jbc.274.17.12115","article-title":"Cross-talk between the aryl hydrocarbon receptor and hypoxia inducible factor signaling pathways. Demonstration of competition and compensation","volume":"274","author":"Chan","year":"1999","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100146_bib193","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1165\/rcmb.2022-0196OC","article-title":"Aryl hydrocarbon receptor agonism antagonizes the hypoxia-driven inflammation in cystic fibrosis","volume":"68","author":"Pariano","year":"2023","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100146_bib194","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202201756","article-title":"Multi-level interaction between HIF and AHR transcriptional pathways in kidney carcinoma","volume":"6","author":"Lafleur","year":"2023","journal-title":"Life Sci Alliance"},{"issue":"21","key":"10.1016\/j.pharmr.2026.100146_bib195","doi-asserted-by":"crossref","first-page":"9926","DOI":"10.1073\/pnas.91.21.9926","article-title":"Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2\/AP1 repeat of the beta-globin locus control region","volume":"91","author":"Moi","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100146_bib196","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/j.bbamcr.2014.05.003","article-title":"Modulation of NRF2 signaling pathway by nuclear receptors: implications for cancer","volume":"1843","author":"Namani","year":"2014","journal-title":"Biochim Biophys Acta"},{"issue":"24","key":"10.1016\/j.pharmr.2026.100146_bib197","doi-asserted-by":"crossref","first-page":"10941","DOI":"10.1128\/MCB.24.24.10941-10953.2004","article-title":"Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex","volume":"24","author":"Zhang","year":"2004","journal-title":"Mol Cell Biol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100146_bib198","doi-asserted-by":"crossref","first-page":"165","DOI":"10.14348\/molcells.2023.0005","article-title":"Anti-ferroptotic effects of Nrf2: beyond the antioxidant response","volume":"46","author":"Shakya","year":"2023","journal-title":"Mol Cells"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100146_bib199","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4110\/in.2009.9.1.12","article-title":"Heme oxygenase-1: its therapeutic roles in inflammatory diseases","volume":"9","author":"Pae","year":"2009","journal-title":"Immune Netw"},{"issue":"21","key":"10.1016\/j.pharmr.2026.100146_bib200","doi-asserted-by":"crossref","first-page":"20340","DOI":"10.1074\/jbc.M412081200","article-title":"Transcriptional regulation of NF-E2 p45-related factor (NRF2) expression by the aryl hydrocarbon receptor-xenobiotic response element signaling pathway: direct cross-talk between phase I and II drug-metabolizing enzymes","volume":"280","author":"Miao","year":"2005","journal-title":"J Biol Chem"},{"issue":"20","key":"10.1016\/j.pharmr.2026.100146_bib201","doi-asserted-by":"crossref","first-page":"7188","DOI":"10.1128\/MCB.00915-07","article-title":"NRF2 modulates aryl hydrocarbon receptor signaling: influence on adipogenesis","volume":"27","author":"Shin","year":"2007","journal-title":"Mol Cell Biol"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100146_bib202","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.bcp.2006.04.017","article-title":"Activation of coupled Ah receptor and Nrf2 gene batteries by dietary phytochemicals in relation to chemoprevention","volume":"72","author":"Kohle","year":"2006","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100146_bib203","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/toxsci\/kfp115","article-title":"Introducing the \u201cTCDD-inducible AhR-Nrf2 gene battery\u201d","volume":"111","author":"Yeager","year":"2009","journal-title":"Toxicol Sci"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100146_bib204","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/exd.14541","article-title":"Aryl hydrocarbon receptor\/nuclear factor E2-related factor 2 (AHR\/NRF2) signalling: a novel therapeutic target for atopic dermatitis","volume":"31","author":"Hwang","year":"2022","journal-title":"Exp Dermatol"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100146_bib205","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/0092-8674(86)90346-6","article-title":"Multiple nuclear factors interact with the immunoglobulin enhancer sequences","volume":"46","author":"Sen","year":"1986","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100146_bib206","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nri.2017.142","article-title":"NF-kappaB, inflammation, immunity and cancer: coming of age","volume":"18","author":"Taniguchi","year":"2018","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100146_bib207","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41392-024-01757-9","article-title":"NF-kappaB in biology and targeted therapy: new insights and translational implications","volume":"9","author":"Guo","year":"2024","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100146_bib208","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0092-8674(00)81694-3","article-title":"IkappaB-NF-kappaB structures: at the interface of inflammation control","volume":"95","author":"Baeuerle","year":"1998","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100146_bib209","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.cell.2008.01.020","article-title":"Shared principles in NF-kappaB signaling","volume":"132","author":"Hayden","year":"2008","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100146_bib210","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1074\/jbc.274.1.510","article-title":"Ah receptor and NF-kappaB interactions, a potential mechanism for dioxin toxicity","volume":"274","author":"Tian","year":"1999","journal-title":"J Biol Chem"},{"issue":"43","key":"10.1016\/j.pharmr.2026.100146_bib211","doi-asserted-by":"crossref","first-page":"39638","DOI":"10.1074\/jbc.M106286200","article-title":"Mechanism of suppression of cytochrome P-450 1A1 expression by tumor necrosis factor-\u03b1 and lipopolysaccharide","volume":"276","author":"Ke","year":"2001","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100146_bib212","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1074\/jbc.M113.505578","article-title":"Cross-talk between aryl hydrocarbon receptor and the inflammatory response: a role for nuclear factor-kappaB","volume":"289","author":"Vogel","year":"2014","journal-title":"J Biol Chem"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100146_bib213","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0006-2952(99)00406-2","article-title":"Activation of transcription factors activator protein-1 and nuclear factor-kappaB by 2,3,7,8-tetrachlorodibenzo-p-dioxin","volume":"59","author":"Puga","year":"2000","journal-title":"Biochem Pharmacol"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100146_bib214","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1210\/me.2007-0211","article-title":"RelB, a new partner of aryl hydrocarbon receptor-mediated transcription","volume":"21","author":"Vogel","year":"2007","journal-title":"Mol Endocrinol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100146_bib215","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/nm.4106","article-title":"Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor","volume":"22","author":"Rothhammer","year":"2016","journal-title":"Nat Med"},{"issue":"49","key":"10.1016\/j.pharmr.2026.100146_bib216","doi-asserted-by":"crossref","first-page":"45722","DOI":"10.1074\/jbc.M105320200","article-title":"The Stat1 binding motif of the interferon-gamma receptor is sufficient to mediate Stat5 activation and its repression by SOCS3","volume":"276","author":"Woldman","year":"2001","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100146_bib217","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/jimmun\/vkae023","article-title":"The aryl hydrocarbon receptor controls IFN-gamma-induced immune checkpoints PD-L1 and IDO via the JAK\/STAT pathway in lung adenocarcinoma","volume":"214","author":"Snyder","year":"2025","journal-title":"J Immunol"},{"issue":"28","key":"10.1016\/j.pharmr.2026.100146_bib218","doi-asserted-by":"crossref","first-page":"9721","DOI":"10.1073\/pnas.0804231105","article-title":"Aryl hydrocarbon receptor regulates Stat1 activation and participates in the development of Th17 cells","volume":"105","author":"Kimura","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100146_bib219","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.18632\/oncotarget.1637","article-title":"Constitutive IDO expression in human cancer is sustained by an autocrine signaling loop involving IL-6, STAT3 and the AHR","volume":"5","author":"Litzenburger","year":"2014","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100146_bib220","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1124\/mol.104.002915","article-title":"2,3,7,8-Tetrachlorodibenzo-p-dioxin induces suppressor of cytokine signaling 2 in murine B cells","volume":"66","author":"Boverhof","year":"2004","journal-title":"Mol Pharmacol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100146_bib221","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s10565-019-09499-z","article-title":"Down-regulation of aryl hydrocarbon receptor intensifies carcinogen-induced retinal lesion via SOCS3-STAT3 signaling","volume":"36","author":"Tsai","year":"2020","journal-title":"Cell Biol Toxicol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100146_bib222","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/ni.3422","article-title":"Constitutive aryl hydrocarbon receptor signaling constrains type I interferon-mediated antiviral innate defense","volume":"17","author":"Yamada","year":"2016","journal-title":"Nat Immunol"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100146_bib223","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20241184","article-title":"PARP7 inhibits type I interferon signaling to prevent autoimmunity and lung disease","volume":"222","author":"Jeltema","year":"2025","journal-title":"J Exp Med"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100146_bib224","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.116130","article-title":"PARP7 inhibition stabilizes STAT1\/STAT2 and relieves experimental autoimmune encephalomyelitis in mice","volume":"44","author":"Xu","year":"2025","journal-title":"Cell Rep"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100146_bib225","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41392-022-00966-4","article-title":"Targeted protein degradation: mechanisms, strategies and application","volume":"7","author":"Zhao","year":"2022","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100146_bib226","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1073\/pnas.95.6.2727","article-title":"The ubiquitin-proteasome pathway: the complexity and myriad functions of proteins death","volume":"95","author":"Ciechanover","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"48","key":"10.1016\/j.pharmr.2026.100146_bib227","doi-asserted-by":"crossref","first-page":"18504","DOI":"10.1074\/jbc.RA119.009282","article-title":"Aryl hydrocarbon receptor (AhR) regulates adipocyte differentiation by assembling CRL4B ubiquitin ligase to target PPARgamma for proteasomal degradation","volume":"294","author":"Dou","year":"2019","journal-title":"J Biol Chem"},{"issue":"32","key":"10.1016\/j.pharmr.2026.100146_bib228","doi-asserted-by":"crossref","first-page":"13481","DOI":"10.1073\/pnas.0902132106","article-title":"Aryl hydrocarbon receptor suppresses intestinal carcinogenesis in ApcMin\/+ mice with natural ligands","volume":"106","author":"Kawajiri","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"10.1016\/j.pharmr.2026.100146_bib229","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00630-16","article-title":"A molecular mechanism to switch the aryl hydrocarbon receptor from a transcription factor to an E3 ubiquitin ligase","volume":"37","author":"Luecke-Johansson","year":"2017","journal-title":"Mol Cell Biol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100146_bib230","doi-asserted-by":"crossref","first-page":"5415","DOI":"10.1038\/s41467-023-41218-5","article-title":"AhR diminishes the efficacy of chemotherapy via suppressing STING-dependent type-I interferon in bladder cancer","volume":"14","author":"Ma","year":"2023","journal-title":"Nat Commun"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100146_bib231","doi-asserted-by":"crossref","first-page":"G1006","DOI":"10.1152\/ajpgi.00427.2011","article-title":"Src-mediated aryl hydrocarbon and epidermal growth factor receptor cross talk stimulates colon cancer cell proliferation","volume":"302","author":"Xie","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.pharmr.2026.100146_bib232","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2021.106989","article-title":"Unraveling the differential impact of PAHs and dioxin-like compounds on AKR1C3 reveals the EGFR extracellular domain as a critical determinant of the AHR response","volume":"158","author":"Vogeley","year":"2022","journal-title":"Environ Int"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100146_bib233","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/toxsci\/kfi344","article-title":"The aryl hydrocarbon receptor directly regulates expression of the potent mitogen epiregulin","volume":"89","author":"Patel","year":"2006","journal-title":"Toxicol Sci"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100146_bib234","doi-asserted-by":"crossref","first-page":"3604","DOI":"10.1073\/pnas.1815126116","article-title":"AhR controls redox homeostasis and shapes the tumor microenvironment in BRCA1-associated breast cancer","volume":"116","author":"Kubli","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmr.2026.100146_bib235","article-title":"The Ah receptor regulates growth factor expression in head and neck squamous cell carcinoma cell lines","author":"John","year":"2013","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.pharmr.2026.100146_bib236","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2018.09.023","article-title":"Evidence of selective activation of aryl hydrocarbon receptor nongenomic calcium signaling by pyrene","volume":"158","author":"Brinchmann","year":"2018","journal-title":"Biochem Pharmacol"},{"issue":"21","key":"10.1016\/j.pharmr.2026.100146_bib237","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.1128\/MCB.00698-13","article-title":"Structure and dimerization properties of the aryl hydrocarbon receptor PAS-A domain","volume":"33","author":"Wu","year":"2013","journal-title":"Mol Cell Biol"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100146_bib238","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.str.2017.05.008","article-title":"Structural basis for aryl hydrocarbon receptor-mediated gene activation","volume":"25","author":"Schulte","year":"2017","journal-title":"Structure"},{"issue":"21","key":"10.1016\/j.pharmr.2026.100146_bib239","doi-asserted-by":"crossref","first-page":"5431","DOI":"10.1073\/pnas.1617035114","article-title":"Structural hierarchy controlling dimerization and target DNA recognition in the AHR transcriptional complex","volume":"114","author":"Seok","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100146_bib240","doi-asserted-by":"crossref","first-page":"7010","DOI":"10.1038\/s41467-022-34773-w","article-title":"Cryo-EM structure of the agonist-bound Hsp90-XAP2-AHR cytosolic complex","volume":"13","author":"Gruszczyk","year":"2022","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100146_bib241","doi-asserted-by":"crossref","first-page":"6234","DOI":"10.1038\/s41467-022-33858-w","article-title":"Structural insight into the ligand binding mechanism of aryl hydrocarbon receptor","volume":"13","author":"Dai","year":"2022","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100146_bib242","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.str.2022.12.013","article-title":"Cryo-EM structure of the cytosolic AhR complex","volume":"31","author":"Wen","year":"2023","journal-title":"Structure"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100146_bib243","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2023.168411","article-title":"Structural insights into the activation of human aryl hydrocarbon receptor by the environmental contaminant benzo[a]pyrene and structurally related compounds","volume":"436","author":"Kwong","year":"2024","journal-title":"J Mol Biol"},{"key":"10.1016\/j.pharmr.2026.100146_bib244","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1146\/annurev-immunol-032713-120245","article-title":"The aryl hydrocarbon receptor: multitasking in the immune system","volume":"32","author":"Stockinger","year":"2014","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100146_bib245","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.immuni.2017.12.012","article-title":"Regulation of the immune response by the aryl hydrocarbon receptor","volume":"48","author":"Gutierrez-Vazquez","year":"2018","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100146_bib246","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3390\/cancers16030472","article-title":"The aryl hydrocarbon receptor: impact on the tumor immune microenvironment and modulation as a potential therapy","volume":"16","author":"Griffith","year":"2024","journal-title":"Cancers"},{"issue":"23","key":"10.1016\/j.pharmr.2026.100146_bib247","doi-asserted-by":"crossref","first-page":"4259","DOI":"10.1016\/j.cell.2022.10.007","article-title":"Macrophages in health and disease","volume":"185","author":"Park","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.pharmr.2026.100146_bib248","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.lfs.2016.05.001","article-title":"Aryl hydrocarbon receptor influences nitric oxide and arginine production and alters M1\/M2 macrophage polarization","volume":"155","author":"Climaco-Arvizu","year":"2016","journal-title":"Life Sci"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100146_bib249","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ajpath.2019.10.005","article-title":"Cecal tumorigenesis in aryl hydrocarbon receptor-deficient mice depends on cecum-specific mitogen-activated protein kinase pathway activation and inflammation","volume":"190","author":"Matoba","year":"2020","journal-title":"Am J Pathol"},{"key":"10.1016\/j.pharmr.2026.100146_bib250","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.1015386","article-title":"Gut microbiota-derived indole 3-propionic acid partially activates aryl hydrocarbon receptor to promote macrophage phagocytosis and attenuate septic injury","volume":"12","author":"Huang","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100146_bib251","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1038\/s41467-020-17750-z","article-title":"Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-kynurenine","volume":"11","author":"Campesato","year":"2020","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100146_bib252","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.immuni.2022.01.006","article-title":"Tryptophan-derived microbial metabolites activate the aryl hydrocarbon receptor in tumor-associated macrophages to suppress anti-tumor immunity","volume":"55","author":"Hezaveh","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.pharmr.2026.100146_bib253","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.633436","article-title":"Regulatory dendritic cells, T cell tolerance, and dendritic cell therapy for immunologic disease","volume":"12","author":"Ness","year":"2021","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100146_bib254","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.immuni.2017.08.016","article-title":"Aryl hydrocarbon receptor controls monocyte differentiation into dendritic cells versus macrophages","volume":"47","author":"Goudot","year":"2017","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100146_bib255","doi-asserted-by":"crossref","first-page":"66","DOI":"10.4049\/jimmunol.0802997","article-title":"Aryl hydrocarbon receptor activation inhibits in vitro differentiation of human monocytes and Langerhans dendritic cells","volume":"183","author":"Platzer","year":"2009","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100146_bib256","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1164\/rccm.200503-468OC","article-title":"A novel low molecular weight inhibitor of dendritic cells and B cells blocks allergic inflammation","volume":"173","author":"Ettmayer","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pharmr.2026.100146_bib257","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.3389\/fimmu.2019.01973","article-title":"Engagement of nuclear coactivator 7 by 3-hydroxyanthranilic acid enhances activation of aryl hydrocarbon receptor in immunoregulatory dendritic cells","volume":"10","author":"Gargaro","year":"2019","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100146_bib258","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/cdd.2014.125","article-title":"Role and therapeutic value of dendritic cells in central nervous system autoimmunity","volume":"22","author":"Quintana","year":"2015","journal-title":"Cell Death Differ"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100146_bib259","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.bj.2020.10.001","article-title":"Type 1 innate lymphoid cells: soldiers at the front line of immunity","volume":"44","author":"Nabekura","year":"2021","journal-title":"Biomed J"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100146_bib260","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/intimm\/dxab001","article-title":"Localization and site-specific cell-cell interactions of group 2 innate lymphoid cells","volume":"33","author":"Kiniwa","year":"2021","journal-title":"Int Immunol"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100146_bib261","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/s41423-024-01161-x","article-title":"Tissue-specific features of innate lymphoid cells in antiviral defense","volume":"21","author":"Piersma","year":"2024","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.pharmr.2026.100146_bib262","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1033904","article-title":"Innate lymphoid cells: more than just immune cells","volume":"13","author":"Xiong","year":"2022","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100146_bib263","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1084\/jem.20151998","article-title":"The aryl hydrocarbon receptor is required for the maintenance of liver-resident natural killer cells","volume":"213","author":"Zhang","year":"2016","journal-title":"J Exp Med"},{"issue":"30","key":"10.1016\/j.pharmr.2026.100146_bib264","doi-asserted-by":"crossref","first-page":"12391","DOI":"10.1073\/pnas.1302856110","article-title":"Modulation of natural killer cell antitumor activity by the aryl hydrocarbon receptor","volume":"110","author":"Shin","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmr.2026.100146_bib265","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.624284","article-title":"AHR regulates NK cell migration via ASB2-mediated ubiquitination of filamin A","volume":"12","author":"Shin","year":"2021","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100146_bib266","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/ni.2104","article-title":"Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161","volume":"12","author":"Mjosberg","year":"2011","journal-title":"Nat Immunol"},{"issue":"6062","key":"10.1016\/j.pharmr.2026.100146_bib267","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1126\/science.1214914","article-title":"Natural aryl hydrocarbon receptor ligands control organogenesis of intestinal lymphoid follicles","volume":"334","author":"Kiss","year":"2011","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100146_bib268","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.immuni.2011.11.011","article-title":"The aryl hydrocarbon receptor regulates gut immunity through modulation of innate lymphoid cells","volume":"36","author":"Qiu","year":"2012","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100146_bib269","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s00281-013-0393-5","article-title":"Aryl hydrocarbon receptor promotes RORgammat(+) group 3 ILCs and controls intestinal immunity and inflammation","volume":"35","author":"Qiu","year":"2013","journal-title":"Semin Immunopathol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100146_bib270","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/s41590-023-01510-4","article-title":"CD4(+) T cell memory","volume":"24","author":"Kunzli","year":"2023","journal-title":"Nat Immunol"},{"issue":"7191","key":"10.1016\/j.pharmr.2026.100146_bib271","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nature06881","article-title":"The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins","volume":"453","author":"Veldhoen","year":"2008","journal-title":"Nature"},{"issue":"7191","key":"10.1016\/j.pharmr.2026.100146_bib272","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nature06880","article-title":"Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor","volume":"453","author":"Quintana","year":"2008","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100146_bib273","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.immuni.2012.08.024","article-title":"Th22 cells are an important source of IL-22 for host protection against enteropathogenic bacteria","volume":"37","author":"Basu","year":"2012","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100146_bib274","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/ni.1915","article-title":"Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T cell-like and Foxp3(+) regulatory T cells","volume":"11","author":"Gandhi","year":"2010","journal-title":"Nat Immunol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100146_bib275","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nm.3868","article-title":"Metabolic control of type 1 regulatory T cell differentiation by AHR and HIF1-\u03b1","volume":"21","author":"Mascanfroni","year":"2015","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100146_bib276","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111963","article-title":"The aryl hydrocarbon receptor cell intrinsically promotes resident memory CD8(+) T cell differentiation and function","volume":"42","author":"Dean","year":"2023","journal-title":"Cell Rep"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100146_bib277","doi-asserted-by":"crossref","first-page":"5819","DOI":"10.4049\/jimmunol.177.9.5819","article-title":"Aryl hydrocarbon receptor activation impairs the priming but not the recall of influenza virus-specific CD8+ T cells in the lung","volume":"177","author":"Lawrence","year":"2006","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100146_bib278","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.ccell.2018.02.005","article-title":"Tumor-repopulating cells induce PD-1 expression in CD8(+) T cells by transferring kynurenine and AhR activation","volume":"33","author":"Liu","year":"2018","journal-title":"Cancer Cell"},{"issue":"19","key":"10.1016\/j.pharmr.2026.100146_bib279","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2012692118","article-title":"The aryl hydrocarbon receptor suppresses immunity to oral squamous cell carcinoma through immune checkpoint regulation","volume":"118","author":"Kenison","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100146_bib280","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2025.110316","article-title":"The AhR regulates IFN-induced immune checkpoints in lung cancer cells through HNRNPH1, an RNA-binding protein, and INCR1, a novel long non-coding RNA","volume":"301","author":"Lara","year":"2025","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100146_bib281","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/jid.2014.419","article-title":"Activation of the arylhydrocarbon receptor causes immunosuppression primarily by modulating dendritic cells","volume":"135","author":"Bruhs","year":"2015","journal-title":"J Invest Dermatol"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100146_bib282","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.it.2018.10.010","article-title":"The aryl hydrocarbon receptor: connecting immunity to the microenvironment","volume":"39","author":"Shinde","year":"2018","journal-title":"Trends Immunol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100146_bib283","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4172\/2157-7609.1000e116","article-title":"Alternative negative feedback control in the aryl hydrocarbon receptor signaling pathway","volume":"4","author":"Matthews","year":"2013","journal-title":"J Drug Metab Toxicol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100146_bib284","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.yfrne.2010.07.002","article-title":"Dioxins, the aryl hydrocarbon receptor and the central regulation of energy balance","volume":"31","author":"Linden","year":"2010","journal-title":"Front Neuroendocrinol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100146_bib285","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0041-008X(84)90337-5","article-title":"Characterization of the wasting syndrome in rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin","volume":"73","author":"Seefeld","year":"1984","journal-title":"Toxicol Appl Pharmacol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100146_bib286","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1053\/j.gastro.2010.03.033","article-title":"A novel role for the dioxin receptor in fatty acid metabolism and hepatic steatosis","volume":"139","author":"Lee","year":"2010","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100146_bib287","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1006\/taap.1996.0210","article-title":"Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced toxicity","volume":"140","author":"Fernandez-Salguero","year":"1996","journal-title":"Toxicol Appl Pharmacol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100146_bib288","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.etap.2015.07.008","article-title":"Influence of dioxin on the daily variation of insulin sensitivity in mice","volume":"40","author":"Takuma","year":"2015","journal-title":"Environ Toxicol Pharmacol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100146_bib289","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/toxsci\/kfw163","article-title":"Dose-dependent metabolic reprogramming and differential gene expression in TCDD-elicited hepatic fibrosis","volume":"154","author":"Nault","year":"2016","journal-title":"Toxicol Sci"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100146_bib290","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/EDE.0b013e3181c2fc6e","article-title":"Dioxin exposure and insulin resistance in Taiwanese living near a highly contaminated area","volume":"21","author":"Chang","year":"2010","journal-title":"Epidemiology"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100146_bib291","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.2337\/dc06-0543","article-title":"A strong dose-response relation between serum concentrations of persistent organic pollutants and diabetes: results from the National Health and Nutrition Examination Survey 1999\u20132002","volume":"29","author":"Lee","year":"2006","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100146_bib292","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/00001648-199705000-00005","article-title":"Serum dioxin and diabetes mellitus in veterans of Operation Ranch Hand","volume":"8","author":"Henriksen","year":"1997","journal-title":"Epidemiology"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100146_bib293","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12940-020-00658-y","article-title":"Aryl-hydrocarbon receptor binding and the incidence of type 2 diabetes: the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)","volume":"19","author":"Duncan","year":"2020","journal-title":"Environ Health"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100146_bib294","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2021.101234","article-title":"Exposure to persistent organic pollutants and the risk of type 2 diabetes: a case-cohort study","volume":"47","author":"Magliano","year":"2021","journal-title":"Diabetes Metab"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100146_bib295","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1289\/ehp.1205003","article-title":"Obesity is mediated by differential aryl hydrocarbon receptor signaling in mice fed a Western diet","volume":"120","author":"Kerley-Hamilton","year":"2012","journal-title":"Environ Health Perspect"},{"issue":"13","key":"10.1016\/j.pharmr.2026.100146_bib296","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.3390\/cells12131748","article-title":"Deficiency of adipose aryl hydrocarbon receptor protects against diet-induced metabolic dysfunction through sexually dimorphic mechanisms","volume":"12","author":"Haque","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.pharmr.2026.100146_bib297","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.taap.2016.03.011","article-title":"Inhibition of the aryl hydrocarbon receptor prevents Western diet-induced obesity. Model for AHR activation by kynurenine via oxidized-LDL, TLR2\/4, TGF\u03b2, and IDO1","volume":"300","author":"Moyer","year":"2016","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.pharmr.2026.100146_bib298","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.nutres.2017.06.002","article-title":"Obesity and fatty liver are prevented by inhibition of the aryl hydrocarbon receptor in both female and male mice","volume":"44","author":"Moyer","year":"2017","journal-title":"Nutr Res"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100146_bib299","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1038\/s41366-019-0340-1","article-title":"Aryl hydrocarbon receptor agonist indigo protects against obesity-related insulin resistance through modulation of intestinal and metabolic tissue immunity","volume":"43","author":"Lin","year":"2019","journal-title":"Int J Obes"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100146_bib300","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2174\/1389200217666151210125105","article-title":"Indole-3-carbinol (I3C) and its major derivatives: their pharmacokinetics and important roles in hepatic protection","volume":"17","author":"Wang","year":"2016","journal-title":"Curr Drug Metab"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100146_bib301","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/j.jnutbio.2011.12.005","article-title":"Indole-3-carbinol prevents diet-induced obesity through modulation of multiple genes related to adipogenesis, thermogenesis or inflammation in the visceral adipose tissue of mice","volume":"23","author":"Choi","year":"2012","journal-title":"J Nutr Biochem"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100146_bib302","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000241","article-title":"Recent updates on the role of the gut-liver axis in the pathogenesis of NAFLD\/NASH, HCC, and beyond","volume":"7","author":"Ohtani","year":"2023","journal-title":"Hepatol Commun"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100146_bib303","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.celrep.2018.03.109","article-title":"Gut microbiota-derived tryptophan metabolites modulate inflammatory response in hepatocytes and macrophages","volume":"23","author":"Krishnan","year":"2018","journal-title":"Cell Rep"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100146_bib304","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.cmet.2018.07.001","article-title":"Impaired aryl hydrocarbon receptor ligand production by the gut microbiota is a key factor in metabolic syndrome","volume":"28","author":"Natividad","year":"2018","journal-title":"Cell Metab"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100146_bib305","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/s41575-024-01035-7","article-title":"Understanding the therapeutic toolkit for inflammatory bowel disease","volume":"22","author":"Vieujean","year":"2025","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"16","key":"10.1016\/j.pharmr.2026.100146_bib306","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.3390\/molecules29163954","article-title":"Current treatments, emerging therapeutics, and natural remedies for inflammatory bowel disease","volume":"29","author":"Yeshi","year":"2024","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100146_bib307","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/s41385-018-0019-2","article-title":"Aryl hydrocarbon receptor and intestinal immunity","volume":"11","author":"Lamas","year":"2018","journal-title":"Mucosal Immunol"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100146_bib308","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1038\/s44321-024-00135-w","article-title":"The influence of AHR on immune and tissue biology","volume":"16","author":"Stockinger","year":"2024","journal-title":"EMBO Mol Med"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100146_bib309","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.cell.2011.09.025","article-title":"Exogenous stimuli maintain intraepithelial lymphocytes via aryl hydrocarbon receptor activation","volume":"147","author":"Li","year":"2011","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100146_bib310","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023522","article-title":"Activation of aryl hydrocarbon receptor (AhR) leads to reciprocal epigenetic regulation of FoxP3 and IL-17 expression and amelioration of experimental colitis","volume":"6","author":"Singh","year":"2011","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100146_bib311","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/toxsci\/kfac132","article-title":"Increased sensitivity to chemically induced colitis in mice harboring a DNA-binding deficient aryl hydrocarbon receptor","volume":"191","author":"Alvik","year":"2023","journal-title":"Toxicol Sci"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100146_bib312","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.immuni.2018.07.010","article-title":"The environmental sensor AHR protects from inflammatory damage by maintaining intestinal stem cell homeostasis and barrier integrity","volume":"49","author":"Metidji","year":"2018","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100146_bib313","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/SLA.0000000000001874","article-title":"The aryl hydrocarbon receptor is a repressor of inflammation-associated colorectal tumorigenesis in mouse","volume":"264","author":"Diaz-Diaz","year":"2016","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100146_bib314","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.celrep.2016.09.082","article-title":"AHR activation is protective against colitis driven by T cells in humanized mice","volume":"17","author":"Goettel","year":"2016","journal-title":"Cell Rep"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100146_bib315","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1053\/j.gastro.2011.04.007","article-title":"Aryl hydrocarbon receptor-induced signals up-regulate IL-22 production and inhibit inflammation in the gastrointestinal tract","volume":"141","author":"Monteleone","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pharmr.2026.100146_bib316","article-title":"Dietary tryptophan enhances aryl hydrocarbon receptor activation and reduces colitis through microbial metabolism","author":"Rondeau","year":"2025","journal-title":"bioRxiv"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100146_bib317","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/nm.4102","article-title":"CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands","volume":"22","author":"Lamas","year":"2016","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100146_bib318","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1080\/25785826.2019.1599158","article-title":"Treatment with indigo naturalis for inflammatory bowel disease and other immune diseases","volume":"42","author":"Naganuma","year":"2019","journal-title":"Immunol Med"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100146_bib319","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1053\/j.gastro.2017.11.024","article-title":"Efficacy of indigo naturalis in a multicenter randomized controlled trial of patients with ulcerative colitis","volume":"154","author":"Naganuma","year":"2018","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100146_bib320","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0241337","article-title":"Efficacy and safety of short-term therapy with indigo naturalis for ulcerative colitis: an investigator-initiated multicenter double-blind clinical trial","volume":"15","author":"Uchiyama","year":"2020","journal-title":"PLoS One"},{"issue":"17","key":"10.1016\/j.pharmr.2026.100146_bib321","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.3748\/wjg.v19.i17.2718","article-title":"Therapeutic efficacy of the Qing Dai in patients with intractable ulcerative colitis","volume":"19","author":"Suzuki","year":"2013","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100146_bib322","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2021-000813","article-title":"Treatment-refractory ulcerative colitis responsive to indigo naturalis","volume":"8","author":"Saiki","year":"2021","journal-title":"BMJ Open Gastroenterol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100146_bib323","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1159\/000526646","article-title":"Curcumin-QingDai combination as treatment for moderate-severe ulcerative colitis","volume":"16","author":"Ben-Horin","year":"2022","journal-title":"Case Rep Gastroenterol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100146_bib324","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1080\/13880209.2024.2415652","article-title":"Indigo naturalis as a potential drug in the treatment of ulcerative colitis: a comprehensive review of current evidence","volume":"62","author":"Hu","year":"2024","journal-title":"Pharm Biol"},{"issue":"Pt 1","key":"10.1016\/j.pharmr.2026.100146_bib325","article-title":"Clinical efficacy and future application of indigo naturalis in the treatment of ulcerative colitis","volume":"337","author":"Wu","year":"2025","journal-title":"J Ethnopharmacol"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100146_bib327","doi-asserted-by":"crossref","first-page":"S1401","DOI":"10.1016\/S0016-5085(24)03678-3","article-title":"Tu1741 preclinical development of AQ312, a potent and selective small molecule aryl hydrocarbon agonist, for the treatment of inflammatory bowel disease","volume":"166","author":"Johansson","year":"2024","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100146_bib328","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41572-018-0054-z","article-title":"Coeliac disease","volume":"5","author":"Lindfors","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.pharmr.2026.100146_bib329","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3389\/fimmu.2019.00091","article-title":"Protective effects of aryl hydrocarbon receptor signaling in celiac disease mucosa and in Poly I:C-induced small intestinal atrophy mouse model","volume":"10","author":"Dinallo","year":"2019","journal-title":"Front Immunol"},{"issue":"566","key":"10.1016\/j.pharmr.2026.100146_bib330","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aba0624","article-title":"Aryl hydrocarbon receptor ligand production by the gut microbiota is decreased in celiac disease leading to intestinal inflammation","volume":"12","author":"Lamas","year":"2020","journal-title":"Sci Transl Med"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100146_bib331","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202002350R","article-title":"Aryl hydrocarbon receptor deficiency causes the development of chronic obstructive pulmonary disease through the integration of multiple pathogenic mechanisms","volume":"35","author":"Guerrina","year":"2021","journal-title":"FASEB J"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100146_bib332","doi-asserted-by":"crossref","first-page":"5539","DOI":"10.4049\/jimmunol.1501198","article-title":"Aryl hydrocarbon receptor protects lungs from cockroach allergen-induced inflammation by modulating mesenchymal stem cells","volume":"195","author":"Xu","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.pharmr.2026.100146_bib333","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.720196","article-title":"Differential regulation of the asthmatic phenotype by the aryl hydrocarbon receptor","volume":"12","author":"Traboulsi","year":"2021","journal-title":"Front Physiol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100146_bib334","article-title":"TCDD-induced activation of aryl hydrocarbon receptor inhibits Th17 polarization and regulates non-eosinophilic airway inflammation in asthma","volume":"11","author":"Li","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmr.2026.100146_bib335","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3389\/fimmu.2020.00144","article-title":"Ozone-induced aryl hydrocarbon receptor activation controls lung inflammation via interleukin-22 modulation","volume":"11","author":"Michaudel","year":"2020","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100146_bib336","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1111\/all.13462","article-title":"Aryl hydrocarbon receptor activation by diesel exhaust particles mediates epithelium-derived cytokines expression in severe allergic asthma","volume":"73","author":"Weng","year":"2018","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100146_bib337","doi-asserted-by":"crossref","first-page":"5198","DOI":"10.1038\/s41598-018-23542-9","article-title":"A prominent air pollutant, indeno[1,2,3-cd]pyrene, enhances allergic lung inflammation via aryl hydrocarbon receptor","volume":"8","author":"Wong","year":"2018","journal-title":"Sci Rep"},{"issue":"22","key":"10.1016\/j.pharmr.2026.100146_bib338","doi-asserted-by":"crossref","first-page":"8797","DOI":"10.3390\/ijms21228797","article-title":"The aryl hydrocarbon receptor in asthma: friend or foe?","volume":"21","author":"Poulain-Godefroy","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100146_bib339","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.rmed.2011.11.003","article-title":"The effects of cigarette smoke on airway inflammation in asthma and COPD: therapeutic implications","volume":"106","author":"Tamimi","year":"2012","journal-title":"Respir Med"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100146_bib340","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1465-9921-11-99","article-title":"Inflammatory changes in the airways of mice caused by cigarette smoke exposure are only partially reversed after smoking cessation","volume":"11","author":"Braber","year":"2010","journal-title":"Respir Res"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100146_bib341","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.toxlet.2008.01.006","article-title":"Interleukin-8 induction by the environmental contaminant benzo(a)pyrene is aryl hydrocarbon receptor-dependent and leads to lung inflammation","volume":"177","author":"Podechard","year":"2008","journal-title":"Toxicol Lett"},{"issue":"24","key":"10.1016\/j.pharmr.2026.100146_bib342","doi-asserted-by":"crossref","first-page":"6046","DOI":"10.3390\/molecules25246046","article-title":"Diesel exhaust particulates induce neutrophilic lung inflammation by modulating endoplasmic reticulum stress-mediated CXCL1\/KC expression in alveolar macrophages","volume":"25","author":"Kim","year":"2020","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100146_bib343","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157058","article-title":"Diesel exhaust particles upregulate interleukins IL-6 and IL-8 in nasal fibroblasts","volume":"11","author":"Kim","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100146_bib344","doi-asserted-by":"crossref","first-page":"855","DOI":"10.2353\/ajpath.2007.060391","article-title":"Aryl hydrocarbon receptor-deficient mice develop heightened inflammatory responses to cigarette smoke and endotoxin associated with rapid loss of the nuclear factor-kappaB component RelB","volume":"170","author":"Thatcher","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.pharmr.2026.100146_bib345","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.630427","article-title":"The aryl hydrocarbon receptor attenuates acute cigarette smoke-induced airway neutrophilia independent of the dioxin response element","volume":"12","author":"Rico de Souza","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.pharmr.2026.100146_bib346","article-title":"The aryl hydrocarbon receptor promotes the resolution of pulmonary neutrophilia via regulation of macrophage efferocytosis","author":"Traboulsi","year":"2025","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100146_bib347","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.immuni.2014.04.019","article-title":"Activation of the aryl hydrocarbon receptor dampens the severity of inflammatory skin conditions","volume":"40","author":"Di Meglio","year":"2014","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100146_bib348","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00281-013-0394-4","article-title":"Functions of the aryl hydrocarbon receptor in the skin","volume":"35","author":"Esser","year":"2013","journal-title":"Semin Immunopathol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100146_bib349","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.3390\/ijms26041618","article-title":"The aryl hydrocarbon receptor (AHR): peacekeeper of the skin","volume":"26","author":"Dawe","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"21","key":"10.1016\/j.pharmr.2026.100146_bib350","doi-asserted-by":"crossref","first-page":"8851","DOI":"10.1073\/pnas.0701764104","article-title":"Lightening up the UV response by identification of the arylhydrocarbon receptor as a cytoplasmatic target for ultraviolet B radiation","volume":"104","author":"Fritsche","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100146_bib351","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1124\/pr.114.009001","article-title":"The aryl hydrocarbon receptor in barrier organ physiology, immunology, and toxicology","volume":"67","author":"Esser","year":"2015","journal-title":"Pharmacol Rev"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100146_bib352","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1111\/exd.14409","article-title":"The aryl hydrocarbon receptor at the forefront of host-microbe interactions in the skin: a perspective on current knowledge gaps and directions for future research and therapeutic applications","volume":"30","author":"van den Bogaard","year":"2021","journal-title":"Exp Dermatol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100146_bib353","first-page":"917","article-title":"Coal tar induces AHR-dependent skin barrier repair in atopic dermatitis","volume":"123","author":"van den Bogaard","year":"2013","journal-title":"J Clin Invest"},{"issue":"14","key":"10.1016\/j.pharmr.2026.100146_bib354","doi-asserted-by":"crossref","first-page":"7910","DOI":"10.3390\/ijms25147910","article-title":"Difamilast, a topical phosphodiesterase 4 inhibitor, produces soluble ST2 via the AHR-NRF2 axis in human keratinocytes","volume":"25","author":"Tsuji","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100146_bib355","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jaad.2024.05.023","article-title":"Tapinarof cream 1% once daily: significant efficacy in the treatment of moderate to severe atopic dermatitis in adults and children down to 2 years of age in the pivotal phase 3 ADORING trials","volume":"91","author":"Silverberg","year":"2024","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100146_bib356","doi-asserted-by":"crossref","first-page":"4329","DOI":"10.1128\/aem.61.12.4329-4333.1995","article-title":"Identification of two pigments and a hydroxystilbene antibiotic from Photorhabdus luminescens","volume":"61","author":"Li","year":"1995","journal-title":"Appl Environ Microbiol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100146_bib357","first-page":"219","article-title":"Antibiotic production in relation to bacterial growth and nematode development in Photorhabdus-Heterorhabditis infected Galleria mellonella larvae","volume":"189","author":"Hu","year":"2000","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.pharmr.2026.100146_bib358","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2025.117559","article-title":"Dual activation of AhR and Nrf2 pathways by the natural stilbenoid tapinarof protects against particulate matter-induced skin barrier dysfunction","volume":"505","author":"Lin","year":"2025","journal-title":"Toxicol Appl Pharmacol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100146_bib359","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.jaad.2022.06.1171","article-title":"One-year safety and efficacy of tapinarof cream for the treatment of plaque psoriasis: results from the PSOARING 3 trial","volume":"87","author":"Strober","year":"2022","journal-title":"J Am Acad Dermatol"},{"issue":"24","key":"10.1016\/j.pharmr.2026.100146_bib360","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1097\/CM9.0000000000001221","article-title":"A double-blind, randomized, placebo- and positive-controlled phase III trial of 1% benvitimod cream in mild-to-moderate plaque psoriasis","volume":"133","author":"Cai","year":"2020","journal-title":"Chin Med J"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100146_bib361","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1111\/1346-8138.17423","article-title":"Tapinarof cream for the treatment of plaque psoriasis: efficacy and safety results from 2 Japanese phase 3 trials","volume":"51","author":"Igarashi","year":"2024","journal-title":"J Dermatol"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100146_bib362","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/cpdd.439","article-title":"Systemic pharmacokinetics, safety, and preliminary efficacy of topical AhR agonist tapinarof: results of a phase 1 study","volume":"7","author":"Bissonnette","year":"2018","journal-title":"Clin Pharmacol Drug Dev"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100146_bib363","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1016\/j.jaad.2021.03.006","article-title":"Tapinarof-associated folliculitis is generally mild, self-limiting, and rarely interferes with therapy","volume":"85","author":"Bissonnette","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100146_bib364","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.jaad.2025.05.1391","article-title":"Skin clearance, duration of treatment-free interval, and safety of tapinarof cream 1% once daily: results from ADORING 3, a 48-week phase 3 open-label extension trial in adults and children down to 2 years of age with atopic dermatitis","volume":"93","author":"Bissonnette","year":"2025","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.pharmr.2026.100146_bib365","doi-asserted-by":"crossref","DOI":"10.1097\/CM9.0000000000003769","article-title":"Efficacy and safety of benvitimod 1% cream for atopic dermatitis in patients aged 2 years and older: a phase III randomized clinical trial","author":"Zhao","year":"2025","journal-title":"Chin Med J"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100146_bib366","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1111\/1346-8138.17451","article-title":"Tapinarof cream for the treatment of atopic dermatitis: efficacy and safety results from two Japanese phase 3 trials","volume":"51","author":"Igarashi","year":"2024","journal-title":"J Dermatol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100146_bib367","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/1346-8138.17587","article-title":"A phase 2, randomized, double-blind, vehicle-controlled trial of tapinarof cream in Japanese pediatric patients with atopic dermatitis","volume":"52","author":"Igarashi","year":"2025","journal-title":"J Dermatol"},{"issue":"7707","key":"10.1016\/j.pharmr.2026.100146_bib368","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/s41586-018-0119-x","article-title":"Microglial control of astrocytes in response to microbial metabolites","volume":"557","author":"Rothhammer","year":"2018","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100146_bib369","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/s41590-018-0107-1","article-title":"Apoptotic cell-induced AhR activity is required for immunological tolerance and suppression of systemic lupus erythematosus in mice and humans","volume":"19","author":"Shinde","year":"2018","journal-title":"Nat Immunol"},{"issue":"10422","key":"10.1016\/j.pharmr.2026.100146_bib370","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0140-6736(23)01473-3","article-title":"Multiple sclerosis","volume":"403","author":"Jakimovski","year":"2024","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100146_bib371","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S1474-4422(18)30443-5","article-title":"Global, regional, and national burden of multiple sclerosis 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"18","author":"Wallin","year":"2019","journal-title":"Lancet Neurol"},{"issue":"48","key":"10.1016\/j.pharmr.2026.100146_bib372","doi-asserted-by":"crossref","first-page":"20768","DOI":"10.1073\/pnas.1009201107","article-title":"An endogenous aryl hydrocarbon receptor ligand acts on dendritic cells and T cells to suppress experimental autoimmune encephalomyelitis","volume":"107","author":"Quintana","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"46","key":"10.1016\/j.pharmr.2026.100146_bib373","doi-asserted-by":"crossref","first-page":"19961","DOI":"10.1073\/pnas.1014465107","article-title":"Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism","volume":"107","author":"Nguyen","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100146_bib374","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1111\/bph.12205","article-title":"Indoles mitigate the development of experimental autoimmune encephalomyelitis by induction of reciprocal differentiation of regulatory T cells and Th17 cells","volume":"169","author":"Rouse","year":"2013","journal-title":"Br J Pharmacol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100146_bib375","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1124\/mol.107.038984","article-title":"Resveratrol (trans-3,5,4\u2032-trihydroxystilbene) ameliorates experimental allergic encephalomyelitis, primarily via induction of apoptosis in T cells involving activation of aryl hydrocarbon receptor and estrogen receptor","volume":"72","author":"Singh","year":"2007","journal-title":"Mol Pharmacol"},{"issue":"41","key":"10.1016\/j.pharmr.2026.100146_bib376","doi-asserted-by":"crossref","first-page":"E6145","DOI":"10.1073\/pnas.1607843113","article-title":"Laquinimod arrests experimental autoimmune encephalomyelitis by activating the aryl hydrocarbon receptor","volume":"113","author":"Kaye","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100146_bib377","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1056\/NEJMoa1104318","article-title":"Placebo-controlled trial of oral laquinimod for multiple sclerosis","volume":"366","author":"Comi","year":"2012","journal-title":"N Engl J Med"},{"issue":"9630","key":"10.1016\/j.pharmr.2026.100146_bib378","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1016\/S0140-6736(08)60918-6","article-title":"Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study","volume":"371","author":"Comi","year":"2008","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100146_bib379","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s00415-014-7264-4","article-title":"A randomized placebo-controlled phase III trial of oral laquinimod for multiple sclerosis","volume":"261","author":"Vollmer","year":"2014","journal-title":"J Neurol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100146_bib380","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1177\/13524585211032803","article-title":"CONCERTO: a randomized, placebo-controlled trial of oral laquinimod in relapsing-remitting multiple sclerosis","volume":"28","author":"Comi","year":"2022","journal-title":"Mult Scler"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100146_bib381","doi-asserted-by":"crossref","first-page":"e1027","DOI":"10.1212\/WNL.0000000000010284","article-title":"A randomized, placebo-controlled, phase 2 trial of laquinimod in primary progressive multiple sclerosis","volume":"95","author":"Giovannoni","year":"2020","journal-title":"Neurology"},{"issue":"17","key":"10.1016\/j.pharmr.2026.100146_bib382","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1001\/jama.2024.2315","article-title":"Systemic lupus erythematosus: a review","volume":"331","author":"Siegel","year":"2024","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100146_bib383","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/08916934.2018.1494161","article-title":"Immunoregulatory effects of indole-3-carbinol on monocyte-derived macrophages in systemic lupus erythematosus: a crucial role for aryl hydrocarbon receptor","volume":"51","author":"Mohammadi","year":"2018","journal-title":"Autoimmunity"},{"key":"10.1016\/j.pharmr.2026.100146_bib384","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.coi.2020.10.014","article-title":"Type I interferon in the pathogenesis of systemic lupus erythematosus","volume":"67","author":"Postal","year":"2020","journal-title":"Curr Opin Immunol"},{"issue":"8022","key":"10.1016\/j.pharmr.2026.100146_bib385","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/s41586-024-07627-2","article-title":"Interferon subverts an AHR-JUN axis to promote CXCL13(+) T cells in lupus","volume":"631","author":"Law","year":"2024","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100146_bib386","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.903","article-title":"AhR agonist tapinarof ameliorates lupus autoimmunity by suppressing Tfh cell differentiation via regulation of the JAK2-STAT3 signaling pathway","volume":"11","author":"Zhang","year":"2023","journal-title":"Immun Inflamm Dis"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100146_bib387","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3390\/cells7100161","article-title":"Pathogenic role of immune cells in rheumatoid arthritis: implications in clinical treatment and biomarker development","volume":"7","author":"Yap","year":"2018","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100146_bib388","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1093\/rheumatology\/ken259","article-title":"A role for the aryl hydrocarbon receptor and the dioxin TCDD in rheumatoid arthritis","volume":"47","author":"Kobayashi","year":"2008","journal-title":"Rheumatology"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100146_bib389","doi-asserted-by":"crossref","first-page":"22279","DOI":"10.3390\/ijms151222279","article-title":"Smoking and rheumatoid arthritis","volume":"15","author":"Chang","year":"2014","journal-title":"Int J Mol Sci"},{"issue":"18","key":"10.1016\/j.pharmr.2026.100146_bib390","doi-asserted-by":"crossref","first-page":"4755","DOI":"10.1073\/pnas.1722124115","article-title":"Shared epitope-aryl hydrocarbon receptor crosstalk underlies the mechanism of gene-environment interaction in autoimmune arthritis","volume":"115","author":"Fu","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100146_bib391","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1124\/jpet.113.209726","article-title":"Aryl hydrocarbon receptor antagonism attenuates growth factor expression, proliferation, and migration in fibroblast-like synoviocytes from patients with rheumatoid arthritis","volume":"348","author":"Lahoti","year":"2014","journal-title":"J Pharmacol Exp Ther"},{"issue":"34","key":"10.1016\/j.pharmr.2026.100146_bib392","doi-asserted-by":"crossref","first-page":"14222","DOI":"10.1073\/pnas.1111786108","article-title":"Aryl hydrocarbon receptor deficiency in T cells suppresses the development of collagen-induced arthritis","volume":"108","author":"Nakahama","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100146_bib393","doi-asserted-by":"crossref","first-page":"213","DOI":"10.21037\/atm-23-1074","article-title":"Indole-3-pyruvic acid alleviates rheumatoid arthritis via the aryl hydrocarbon receptor pathway","volume":"11","author":"Huang","year":"2023","journal-title":"Ann Transl Med"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100146_bib394","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.bcp.2008.10.031","article-title":"The aryl hydrocarbon receptor is a modulator of anti-viral immunity","volume":"77","author":"Head","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmr.2026.100146_bib395","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.624293","article-title":"The aryl hydrocarbon receptor as a modulator of anti-viral immunity","volume":"12","author":"Torti","year":"2021","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100146_bib396","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/toxsci\/56.1.114","article-title":"Exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) suppresses the humoral and cell-mediated immune responses to influenza A virus without affecting cytolytic activity in the lung","volume":"56","author":"Warren","year":"2000","journal-title":"Toxicol Sci"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100146_bib397","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.cbi.2005.06.004","article-title":"Increased mortality associated with TCDD exposure in mice infected with influenza A virus is not due to severity of lung injury or alterations in Clara cell protein content","volume":"155","author":"Bohn","year":"2005","journal-title":"Chem Biol Interact"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100146_bib398","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/toxsci\/kft255","article-title":"Differential consequences of two distinct AhR ligands on innate and adaptive immune responses to influenza A virus","volume":"137","author":"Wheeler","year":"2014","journal-title":"Toxicol Sci"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100146_bib399","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.4049\/jimmunol.2100936","article-title":"The aryl hydrocarbon receptor modulates T follicular helper cell responses to influenza virus infection in mice","volume":"208","author":"Houser","year":"2022","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100146_bib400","doi-asserted-by":"crossref","first-page":"659","DOI":"10.4049\/jimmunol.1201341","article-title":"Novel cellular targets of AhR underlie alterations in neutrophilic inflammation and inducible nitric oxide synthase expression during influenza virus infection","volume":"190","author":"Wheeler","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.pharmr.2026.100146_bib401","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2024.117010","article-title":"Timing influences the impact of aryl hydrocarbon receptor activation on the humoral immune response to respiratory viral infection","volume":"489","author":"Houser","year":"2024","journal-title":"Toxicol Appl Pharmacol"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100146_bib402","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.3390\/v14071347","article-title":"ARNT inhibits H5N1 influenza A virus replication by interacting with the PA protein","volume":"14","author":"Feng","year":"2022","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100146_bib403","doi-asserted-by":"crossref","first-page":"5148","DOI":"10.1038\/s41467-021-25412-x","article-title":"AHR signaling is induced by infection with coronaviruses","volume":"12","author":"Giovannoni","year":"2021","journal-title":"Nat Commun"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100146_bib404","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.3390\/v14112437","article-title":"Canine coronavirus activates aryl hydrocarbon receptor during in vitro infection","volume":"14","author":"Cerracchio","year":"2022","journal-title":"Viruses"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100146_bib405","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/JVI.01743-19","article-title":"Murine coronavirus infection activates the aryl hydrocarbon receptor in an indoleamine 2,3-dioxygenase-independent manner, contributing to cytokine modulation and proviral TCDD-inducible-PARP expression","volume":"94","author":"Grunewald","year":"2020","journal-title":"J Virol"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100146_bib406","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.3390\/antibiotics12081319","article-title":"In vitro evaluation of antiviral activities of funicone-like compounds vermistatin and penisimplicissin against canine coronavirus infection","volume":"12","author":"Cerracchio","year":"2023","journal-title":"Antibiotic"},{"key":"10.1016\/j.pharmr.2026.100146_bib407","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2023.105570","article-title":"Pinostrobin from plants and propolis against human coronavirus HCoV-OC43 by modulating host AHR\/CYP1A1 pathway and lipid metabolism","volume":"212","author":"Zhao","year":"2023","journal-title":"Antiviral Res"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100146_bib408","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41422-020-00435-z","article-title":"Mucus production stimulated by IFN-AhR signaling triggers hypoxia of COVID-19","volume":"30","author":"Liu","year":"2020","journal-title":"Cell Res"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100146_bib409","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.4049\/jimmunol.1101575","article-title":"Aryl hydrocarbon receptor-mediated induction of EBV reactivation as a risk factor for Sjogren's syndrome","volume":"188","author":"Inoue","year":"2012","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100146_bib410","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/mBio.02591-19","article-title":"Tryptophan metabolism activates aryl hydrocarbon receptor-mediated pathway to promote HIV-1 infection and reactivation","volume":"10","author":"Zhou","year":"2019","journal-title":"mBio"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100146_bib411","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/s41593-020-0664-0","article-title":"AHR is a Zika virus host factor and a candidate target for antiviral therapy","volume":"23","author":"Giovannoni","year":"2020","journal-title":"Nat Neurosci"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100146_bib412","doi-asserted-by":"crossref","DOI":"10.1128\/Spectrum.00473-21","article-title":"Targeting aryl hydrocarbon receptor signaling enhances type I interferon-independent resistance to herpes simplex virus","volume":"9","author":"Chen","year":"2021","journal-title":"Microbiol Spectr"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100146_bib413","doi-asserted-by":"crossref","DOI":"10.1080\/21505594.2022.2158663","article-title":"Epithelial cell invasion by Salmonella typhimurium induces modulation of genes controlled by aryl hydrocarbon receptor signaling and involved in extracellular matrix biogenesis","volume":"14","author":"Chausse","year":"2023","journal-title":"Virulence"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100146_bib414","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009774","article-title":"Aryl hydrocarbon receptor activation by Lactobacillus reuteri tryptophan metabolism alleviates Escherichia coli-induced mastitis in mice","volume":"17","author":"Zhao","year":"2021","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.pharmr.2026.100146_bib415","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1726557","article-title":"Commensal staphylococci attenuate Staphylococcus aureus skin colonization and inflammation via AHR-dependent signaling","volume":"16","author":"Riebelmann","year":"2025","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100146_bib416","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1159\/000524033","article-title":"Staphylococcus aureus activates the aryl hydrocarbon receptor in human keratinocytes","volume":"14","author":"Stange","year":"2022","journal-title":"J Innate Immun"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100146_bib417","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13364","article-title":"Porphyromonas gingivalis infection promotes inflammation via inhibition of the AhR signalling pathway in periodontitis","volume":"56","author":"Hao","year":"2023","journal-title":"Cell Prolif"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100146_bib418","doi-asserted-by":"crossref","DOI":"10.1016\/j.micinf.2022.105097","article-title":"Chlamydia trachomatis relies on the scavenger role of aryl hydrocarbon receptor with detyrosinated tubulin for its intracellular growth, but this is impaired by excess indole","volume":"25","author":"Zhang","year":"2023","journal-title":"Microbes Infect"},{"issue":"15","key":"10.1016\/j.pharmr.2026.100146_bib419","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.7150\/jca.26083","article-title":"Involvement of aryl hydrocarbon receptor and aryl hydrocarbon receptor repressor in Helicobacter pylori-related gastric pathogenesis","volume":"9","author":"Zhu","year":"2018","journal-title":"J Cancer"},{"key":"10.1016\/j.pharmr.2026.100146_bib420","doi-asserted-by":"crossref","first-page":"880","DOI":"10.3389\/fimmu.2017.00880","article-title":"The IDO-AhR axis controls Th17\/Treg immunity in a pulmonary model of fungal infection","volume":"8","author":"de Araujo","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.pharmr.2026.100146_bib421","article-title":"Intestinal flora-derived kynurenic acid protects against intestinal damage caused by Candida albicans infection via activation of aryl hydrocarbon receptor","volume":"13","author":"Wang","year":"2022","journal-title":"Front Microbiol"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100146_bib422","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1007\/s00204-017-1981-2","article-title":"Role of the aryl hydrocarbon receptor in carcinogenesis and potential as an anti-cancer drug target","volume":"91","author":"Kolluri","year":"2017","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.pharmr.2026.100146_bib423","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1375905","article-title":"The aryl hydrocarbon receptor as a tumor modulator: mechanisms to therapy","volume":"14","author":"Chaudhry","year":"2024","journal-title":"Front Oncol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100146_bib424","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1124\/mol.109.059675","article-title":"Aryl hydrocarbon receptor regulates cell cycle progression in human breast cancer cells via a functional interaction with cyclin-dependent kinase 4","volume":"77","author":"Barhoover","year":"2010","journal-title":"Mol Pharmacol"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100146_bib425","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013831","article-title":"Breast cancer stem-like cells are inhibited by a non-toxic aryl hydrocarbon receptor agonist","volume":"5","author":"Prud'homme","year":"2010","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100146_bib426","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1158\/1541-7786.MCR-11-0502","article-title":"FOXA1 is essential for aryl hydrocarbon receptor-dependent regulation of cyclin G2","volume":"10","author":"Ahmed","year":"2012","journal-title":"Mol Cancer Res"},{"issue":"13","key":"10.1016\/j.pharmr.2026.100146_bib427","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1101\/gad.13.13.1742","article-title":"p27(Kip1) induction and inhibition of proliferation by the intracellular Ah receptor in developing thymus and hepatoma cells","volume":"13","author":"Kolluri","year":"1999","journal-title":"Genes Dev"},{"issue":"16","key":"10.1016\/j.pharmr.2026.100146_bib428","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1002\/1873-3468.14434","article-title":"The cyclin-dependent kinase inhibitor p27(Kip1) interacts with the aryl hydrocarbon receptor and negatively regulates its transcriptional activity","volume":"596","author":"Elson","year":"2022","journal-title":"FEBS Lett"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100146_bib429","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1128\/MCB.23.6.1843-1855.2003","article-title":"The aryl hydrocarbon receptor mediates degradation of estrogen receptor \u03b1 through activation of proteasomes","volume":"23","author":"Wormke","year":"2003","journal-title":"Mol Cell Biol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100146_bib430","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/carcin\/bgl179","article-title":"The aryl hydrocarbon receptor inhibits prostate carcinogenesis in TRAMP mice","volume":"28","author":"Fritz","year":"2007","journal-title":"Carcinogenesis"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100146_bib431","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1039\/D1LC00854D","article-title":"Analysis of the effects of aryl hydrocarbon receptor expression on cancer cell invasion via three-dimensional microfluidic invasion assays","volume":"22","author":"Li","year":"2022","journal-title":"Lab Chip"},{"key":"10.1016\/j.pharmr.2026.100146_bib432","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115706","article-title":"Suppression of Ah receptor (AhR) increases the aggressiveness of TNBC cells and 11-Cl-BBQ-activated AhR inhibits their growth","volume":"215","author":"Elson","year":"2023","journal-title":"Biochem Pharmacol"},{"issue":"16","key":"10.1016\/j.pharmr.2026.100146_bib433","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.3390\/cancers13164071","article-title":"Loss of aryl hydrocarbon receptor favors K-Ras(G12D)-driven non-small cell lung cancer","volume":"13","author":"Nacarino-Palma","year":"2021","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100146_bib434","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41389-020-00286-8","article-title":"Functional screening identifies aryl hydrocarbon receptor as suppressor of lung cancer metastasis","volume":"9","author":"Nothdurft","year":"2020","journal-title":"Oncogenesis"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100146_bib435","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/s41598-019-56876-z","article-title":"The AHR pathway represses TGF\u03b2-SMAD3 signalling and has a potent tumour suppressive role in SHH medulloblastoma","volume":"10","author":"Saric","year":"2020","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100146_bib436","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1158\/0008-5472.CAN-09-3090","article-title":"The aryl hydrocarbon receptor functions as a tumor suppressor of liver carcinogenesis","volume":"70","author":"Fan","year":"2010","journal-title":"Cancer Res"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100146_bib437","doi-asserted-by":"crossref","first-page":"e670","DOI":"10.1097\/MPA.0000000000002357","article-title":"Aryl hydrocarbon receptor knockout accelerates PanIN formation and fibro-inflammation in a mutant Kras-driven pancreatic cancer model","volume":"53","author":"Walcheck","year":"2024","journal-title":"Pancreas"},{"issue":"39","key":"10.1016\/j.pharmr.2026.100146_bib438","doi-asserted-by":"crossref","first-page":"6059","DOI":"10.1038\/sj.onc.1205633","article-title":"Increased arylhydrocarbon receptor expression offers a potential therapeutic target for pancreatic cancer","volume":"21","author":"Koliopanos","year":"2002","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100146_bib439","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.bbrc.2018.05.061","article-title":"Inhibition of pancreatic cancer Panc1 cell migration by omeprazole is dependent on aryl hydrocarbon receptor activation of JNK","volume":"501","author":"Jin","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100146_bib440","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1021\/tx500485v","article-title":"Aryl hydrocarbon receptor ligand 5F 203 induces oxidative stress that triggers DNA damage in human breast cancer cells","volume":"28","author":"McLean","year":"2015","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.pharmr.2026.100146_bib441","series-title":"A Cancer Research UK phase I trial of Phortress (novel antitumour benzothiazole) given intravenously in consecutive 21 day cycles with treatment on day 1 of each cycle","first-page":"4","author":"Seckl","year":"2012"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100146_bib442","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1158\/1535-7163.MCT-21-0841","article-title":"A whole-genome CRISPR screen identifies AHR loss as a mechanism of resistance to a PARP7 inhibitor","volume":"21","author":"Chen","year":"2022","journal-title":"Mol Cancer Ther"},{"issue":"24","key":"10.1016\/j.pharmr.2026.100146_bib443","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2424985122","article-title":"CRISPR screens and quantitative proteomics reveal remodeling of the aryl hydrocarbon receptor-driven proteome through PARP7 activity","volume":"122","author":"Gorelik","year":"2025","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmr.2026.100146_bib444","doi-asserted-by":"crossref","DOI":"10.1038\/s44321-025-00214-6","article-title":"PARP7 as a new target for activating anti-tumor immunity in cancer","author":"Popova","year":"2025","journal-title":"EMBO Mol Med"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100146_bib445","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s13402-025-01150-w","article-title":"PARP7 and aryl hydrocarbon receptor differentially regulate mammary cancer cell proliferation and STING-induced type I interferon signalling","volume":"49","author":"Olafsen","year":"2025","journal-title":"Cell Oncol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100146_bib446","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1158\/1535-7163.MCT-24-0211","article-title":"PARP7 inhibitors and AHR agonists act synergistically across a wide range of cancer models","volume":"24","author":"Chen","year":"2025","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.pharmr.2026.100146_bib447","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2025.155864","article-title":"Exploring immune checkpoint inhibitors: focus on PD-1\/PD-L1 axis and beyond","volume":"269","author":"Aden","year":"2025","journal-title":"Pathol Res Pract"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100146_bib448","doi-asserted-by":"crossref","first-page":"906","DOI":"10.3390\/cancers17050906","article-title":"Targeting immune checkpoint inhibitors for non-small-cell lung cancer: beyond PD-1\/PD-L1 monoclonal antibodies","volume":"17","author":"Roussot","year":"2025","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100146_bib449","doi-asserted-by":"crossref","first-page":"752","DOI":"10.3390\/ijms22020752","article-title":"AhR and cancer: from gene profiling to targeted therapy","volume":"22","author":"Paris","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100146_bib450","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.4236\/jct.2013.47137","article-title":"The aryl hydrocarbon receptor: a target for breast cancer therapy","volume":"4","author":"Powell","year":"2013","journal-title":"J Cancer Ther"},{"issue":"15","key":"10.1016\/j.pharmr.2026.100146_bib451","doi-asserted-by":"crossref","first-page":"9990","DOI":"10.1073\/pnas.152706299","article-title":"A constitutively active dioxin\/aryl hydrocarbon receptor induces stomach tumors","volume":"99","author":"Andersson","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"17","key":"10.1016\/j.pharmr.2026.100146_bib452","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241713155","article-title":"Targeting AHR increases pancreatic cancer cell sensitivity to gemcitabine through the ELAVL1-DCK pathway","volume":"24","author":"Stukas","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100146_bib453","first-page":"428","article-title":"Cigarette smoke toxins-induced mitochondrial dysfunction and pancreatitis involves aryl hydrocarbon receptor-mediated CYP1 gene expression: protective effects of resveratrol","volume":"166","author":"Ghosh","year":"2018","journal-title":"Toxicol Sci"},{"issue":"24","key":"10.1016\/j.pharmr.2026.100146_bib454","doi-asserted-by":"crossref","first-page":"6795","DOI":"10.1158\/0008-5472.CAN-17-2285","article-title":"Discovery of IDO1 inhibitors: from bench to bedside","volume":"77","author":"Prendergast","year":"2017","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100146_bib455","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.trecan.2017.11.005","article-title":"Inflammatory reprogramming with IDO1 inhibitors: turning immunologically unresponsive \u201ccold\u201d tumors \u201chot\u201d","volume":"4","author":"Prendergast","year":"2018","journal-title":"Trends Cancer"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100146_bib456","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00281-018-0702-0","article-title":"Inhibiting IDO pathways to treat cancer: lessons from the ECHO-301 trial and beyond","volume":"41","author":"Muller","year":"2019","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.pharmr.2026.100146_bib457","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.canlet.2021.09.012","article-title":"IDO1\/TDO dual inhibitor RY103 targets the Kyn-AhR pathway and exhibits preclinical efficacy in pancreatic cancer","volume":"522","author":"Liang","year":"2021","journal-title":"Cancer Lett"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100146_bib458","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1021\/acsmedchemlett.2c00525","article-title":"Inhibitors of interleukin-4-induced protein 1 (IL4I1) as potential treatment for cancer","volume":"14","author":"Abdel-Magid","year":"2023","journal-title":"ACS Med Chem Lett"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100146_bib459","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/s41593-019-0370-y","article-title":"Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39","volume":"22","author":"Takenaka","year":"2019","journal-title":"Nat Neurosci"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100146_bib460","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10787-019-00651-z","article-title":"Therapeutic potential of aryl hydrocarbon receptor in autoimmunity","volume":"28","author":"Wang","year":"2020","journal-title":"Inflammopharmacology"},{"issue":"15","key":"10.1016\/j.pharmr.2026.100146_bib461","doi-asserted-by":"crossref","first-page":"4065","DOI":"10.1158\/0008-5472.CAN-17-0090","article-title":"Intestine-specific homeobox gene ISX integrates IL6 signaling, tryptophan catabolism, and immune suppression","volume":"77","author":"Wang","year":"2017","journal-title":"Cancer Res"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100146_bib463","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-007495","article-title":"Targeting the aryl hydrocarbon receptor (AhR) with BAY 2416964: a selective small-molecule inhibitor for cancer immunotherapy","volume":"11","author":"Kober","year":"2023","journal-title":"J Immunother Cancer"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100146_bib464","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1158\/1535-7163.MCT-21-0984","article-title":"Discovery and characterization of a novel aryl hydrocarbon receptor inhibitor, IK-175, and its inhibitory activity on tumor immune suppression","volume":"21","author":"McGovern","year":"2022","journal-title":"Mol Cancer Ther"},{"issue":"16 Suppl","key":"10.1016\/j.pharmr.2026.100146_bib465","article-title":"Initial results from a first-in-human phase I study of immunomodulatory aryl hydrocarbon receptor inhibitor BAY2416964 in patients with advanced solid tumors","volume":"41","author":"Dumbrava","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.pharmr.2026.100146_bib466","author":"Sumners"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100146_bib468","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1158\/1078-0432.CCR-25-2013","article-title":"IK-175, an oral aryl hydrocarbon receptor inhibitor, alone and with nivolumab in patients with advanced solid tumors and urothelial carcinoma","volume":"32","author":"Aggen","year":"2026","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pharmr.2026.100146_bib469","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2023.03.011","article-title":"Dietary tryptophan metabolite released by intratumoral Lactobacillus reuteri facilitates immune checkpoint inhibitor treatment","author":"Bender","year":"2023","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100146_bib470","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3390\/ph18040471","article-title":"AHR agonist ITE boosted PD1 antibody's effects by inhibiting myeloid-derived cells suppressive cells in an orthotopic mouse glioma model","volume":"18","author":"Gong","year":"2025","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100146_bib471","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-66854-x","article-title":"Physiological activation of aryl hydrocarbon receptor by food-derived ligands is essential for the efficacy of anti-PD-1 therapy","volume":"16","author":"De Juan","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.pharmr.2026.100146_bib472","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111842","article-title":"Targeting aryl hydrocarbon receptor for next-generation immunotherapies: selective modulators (SAhRMs) versus rapidly metabolized ligands (RMAhRLs)","volume":"185","author":"Dolciami","year":"2020","journal-title":"Eur J Med Chem"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100146_bib473","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/s41573-025-01172-x","article-title":"The aryl hydrocarbon receptor: a rehabilitated target for therapeutic immune modulation","volume":"24","author":"Polonio","year":"2025","journal-title":"Nat Rev Drug Discov"}],"container-title":["Pharmacological Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699726000347?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699726000347?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T22:14:23Z","timestamp":1785968063000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031699726000347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":468,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0031699726000347"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmr.2026.100146","relation":{},"ISSN":["0031-6997"],"issn-type":[{"value":"0031-6997","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aryl hydrocarbon receptor pharmacology\u2014mechanisms, ligands, and therapeutic potential","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmr.2026.100146","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"100146"}}